netFormulary
 Report : A-Z of formulary items 23/05/2018 11:49:57
[Back]
 
Section Name Details
16.01  Resource Thicken Up Clear®
06.01.01.02 Insulin glargine 300units/ml Toujeo Solution for injection (injection). Solostar
PRESCRIBE BY BRAND
High strength insulin glargine - 300 units/ml
20 5-Fluorouracil  7.5mg in 0.3ml injection

Approved by HaRD Area Prescribing Committee June 2014
05.03.01 Abacavir Ziagen® Commissioned by NHS England.

All patients should routinely be started on Homecare
05.03.01 Abacavir and Lamivudine and Zidovudine Trizivir® Commissioned by NHS England

All patients should be routinely initiated on Homecare - not stocked at HDH
10.01.03 Abatacept Orencia®

Initiation by Consultant Rheumatologists only.

Commissioned by NHS England

24.16 Abidec Neonatal For all pre-term infants < 34 weeks gestation and/or <1500g birth weight.

Dose: 0.6ml once daily (unlicensed dose)

Commence when tolerated milk feed (formula or breast) ≥ 165ml/kg/day.

Continue up to 6-12 months of age depending on diet.

Dalivit® is available when there are supply problems with Abidec, however the dose is 0.3ml daily due to the higher vitamin A content.
08.03.04.02 Abiraterone Zytiga®
04.10 Acamprosate Calcium Campral EC® Tablets 333mg

Initiation on the advice of a Psychiatrist
11.06 Acetazolamide Diamox® Tablets 250mg
MR capsules 250mg
12.01.01 Acetic acid solution  Solution 3%, 5%
03.07 Acetylcysteine effervescent tablets 600mg  NACSYS Prescribe by brand (NACSYS brand)
NACSYS 600 mg effervescent tablets is indicated in adults only.
18 Acetylcysteine infusion Parvolex®
24.01 Acetylcysteine injection 
05.03.02.01 Aciclovir  Tablets 200mg, 400mg, 800mg
Infusion 250mg/10ml, 500mg/20ml (hospital only)
11.03.03 Aciclovir Zovirax® Eye ointment 3%
24.01 Aciclovir 
  • Oral - follow BNFc
  • IV - follow dosing and administration guide
  • 24.16 Aciclovir Neonatal
    13.10.03 Aciclovir 5% 
    13.05.02 Acitretin Neotigason®
    03.01.02 Aclidinium bromide Eklira Genuair® Licensed for COPD only
    01.05.03 Adalimumab Humira® Consultant request only

    Commissioned by NHS England for paediatric uveitis, juvenile arthritis and paediatric indications (where adult TA available)
    10.01.03 Adalimumab Humira®

    Initiation by Consultant Rheumatologists only

    13.06.01 Adapalene Differin®
    13.06.01 Adapalene Epiduo® Approved by HaRD Area Prescribing Committee September 2013
    02.03.02 Adenosine Adenocor® Injection 6mg/2ml
    24.01 Adenosine 
    24.01 Adrenaline 
    24.16 Adrenaline  Neonatal
    02.07.03 Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 10000, dilute
    03.04.03 Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 1000 Injection 1:1000 1mg/ml
    03.04.03 Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 10000, dilute Injection 1mg/10ml
    Pre-filled syringe 1mg/10ml
    03.04.03 Adrenaline / Epinephrine Minijet® Adrenaline 1 in 10000 Minijet 1mg/10ml
    03.04.03 Adrenaline / Epinephrine  Emerade® 500 micrograms solution for injection in pre-filled pen
    14.04 Adsorbed Diphtheria [low dose], Tetanus and Inactivated Poliomyelitis Vaccine Revaxis®
    14.04 Adsorbed Diphtheria [low dose], Tetanus, Pertussis (Acellular, Component) and Inactivated Poliomyelitis Vaccine Repevax®
    08.01.05 Aflibercept Zaltrap® NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy
    11.08.02 Aflibercept Eylea®
    13.11.01 Alcohol Industrial Methylated Spirit BP
    08.02.03 Alemtuzumab MabCampath® Commissioned by NHS England for the treatment of multiple sclerosis, pre-transplant immunosupression and chronic lymphocytic luekemia (CLL)
    06.06.02 Alendronic Acid  Tablets 70mg

    09.06.04 Alfacalcidol  Capsules 0.25micrograms, 1microgram
    15.01.04.03 Alfentanil Rapifen®
    17 Alfentanil  Opiate of choice in severe renal impairment
    20.01 Alirocumab  Praluent® First line in patients with LDL 3.5-4 (target LDL level 1.8) and in primary prevention (FH) with LDL > 5
    02.05.05.03 Aliskiren Rasilez® Tablets 150mg
    For use by Renal Unit patients or on the advice of a specialist only
    13.05.01 Alitretinoin Toctino® Consultant Dermatologist recommendation only
    10.01.04 Allopurinol  Tablets 100mg, 300mg
    02.14 Alprostadil  Prostin VR® Injection 500microgram/ml

    For use in neonates only
    07.04.05 Alprostadil Caverject®
    07.04.05 Alprostadil MUSE®
    07.04.05 Alprostadil Vitaros® Approved by the HaRD Area Prescribing Committee, February 2015.
    To be prescribed on the recommendation of a Consultant Urologist ONLY.
    24.16 Alprostadil Neonatal 500microgram/ml injection
    02.10.02 Alteplase Actilyse® Injection 20mg, 50mg

    For specialist use only
    13.12 Aluminimum Salts Anhydrol Forte®
    09.05.02.02 Aluminium Hydroxide Alu-Cap® Capsules 475mg

    Initiation on the advice of a Renal Specialist
    01.02 Alverine Citrate Spasmonal®
    05.01.04 Amikacin 
    02.02.03 Amiloride Hydrochloride 
    03.01.03 Aminophylline  Injection 250mg/10ml
    Phyllocontin MR tablets 100mg, 225mg

    Prescribe by brand for different MR formulations of theophylline and aminophylline to avoid confusion between them.
    24.01 Aminophylline 
    24.01 Amiodarone 
    02.03.02 Amiodarone Hydrochloride  Tablets 100mg 200mg; Injection 150mg/3ml; Minijet 300mg/10ml
    04.02.01 Amisulpride  Tablets 50mg, 200mg
    Liquid 500mg/5ml
    04.07.03 Amitriptlyine  Tablets 10mg, 25mg, 50mg
    Liquid 50mg/5ml
    04.03.01 Amitriptyline Hydrochloride  Tablets 10mg, 25mg, 50mg
    Liquid 50mg/5ml
    02.06.02 Amlodipine  Tablets 5mg, 10mg
    13.10.02 Amorolfine Loceryl®
    05.01.01.03 Amoxicillin  Capsules 250mg & 500mg
    Syrup 125mg/5ml & 250mg/5ml
    Injection 250mg, 500mg and 1g powder (hospital only)
    24.01 Amoxicillin 
  • Oral - follow BNFc
  • IV - follow dosing and administration guide
  • 24.16 Amoxicillin Neonatal
    11.99.99.99 Amphotericin  
    09.01.04 Anagrelide Xagrid® Capsules 500micrograms

    Initiation by Consultant Haematologists only
    08.03.04.01 Anastrozole Arimidex® Tablets 1mg
    15.02 Antacid with Oxetacaine 
    14.05.03 Anti-D (Rh0) Immunoglobulin Rhophylac®
    02.08.02 Apixaban Eliquis® See NICE guidance.

    04.09.01 Apomorphine Hydrochloride APO-go® Injection 20mg/2ml, 50mg/5ml

    Initiation on the advice of a specialist
    13.02.01 Aqueous Cream BP  100g, 500g
    13.09 Arachis (peanut) oil Extract of Coal Tar 0.3%, Cade Oil 0.3%,
    Coal Tar Solution 0.1%, Oleyl Alcohol 1% and Tar 0.3%
     Polytar®
    02.08.01 Argatroban Exembol®
    04.02.01 Aripiprazole Abilify® Tablets 5mg, 10mg, 15mg - Not Stocked

    Initiation by Consultant Psychiatrists only, requested through LPG on an individual patient basis.
    05.04.01 Artemether with lumefantrine Riamet® On the advice of the Infectious Diseases Team at Leeds
    12.03.05 AS saliva Orthana®  Product is of animal origin (procine) so therefore not suitable for all patient groups.
    09.06.03 Ascorbic Acid  Tablets 50mg, 200mg, 500mg
    04.07.01 Aspirin  Soluble tablets 300mg
    02.09 Aspirin (antiplatelet) Aspirin® Dispersible tablets 75mg

    Not to be used as monotherapy for atrial fibrilation

    02.04 Atenolol  Tablets 25mg, 50mg, 100mg; Liquid 25mg/5ml; Injection 5mg/10ml
    04.04 Atomoxetine Strattera® Capsules 10mg

    Initiation on the advice of a specialist
    02.12 Atorvastatin Lipitor® Tablets 10mg, 20mg, 40mg, 80mg

    Initiation by a specialist only.
    Atorvastatin 80mg OD for use post ACS for 6 months then switch to simvastatin 40mg if target cholesterol achieved.
    07.01.03 Atosiban Tractocile® Injection 7.5mg/ml (5ml)
    Concentrate for infusion 7.5mg/ml (0.9ml)
    24.16 Atracurium Neonatal
    15.01.05 Atracurium Besilate 
    24.16 Atropine Neonatal
    11.05 Atropine Sulphate  Eye drops 1%
    Eye ointment 1%
    15.01.03 Atropine Sulphate 
    07.04.05 Avanafil Spedra®
    08.01.03 Azacitidine Vidaza®
    08.02.01 Azathioprine  Tablets 25mg, 50mg
    10.01.03 Azathioprine  Tablets 25mg, 50mg
    13.06.01 Azelaic Acid Finacae®
    12.02.01 Azelastine Hydrochloride Rhinolast® Aqueous nasal spray 140micrograms/metered spray
    05.01.05 Azithromycin  Long term use of Azithromycin in non – cystic bronchiectasis is an ‘off-label’ use for azithromycin.
    To be initiated by the specialist Respiratory Team only.
    05.01.02.03 Aztreonam Azactam® Injection 1g powder
    10.02.02 Baclofen  Tablets 10mg
    Liquid 5mg/5ml
    01.05.01 Balsalazide Sodium Colazide® Capsules 750mg
    10.01.03 Baricitinib Olumiant
    13.02.02 Barrier preparation Conotrane® 100g
    13.02.02 Barrier preparation Sudocrem®
    13.02.02 Barrier preparation Metanium® Ointment 30g
    13.02.02 Barrier preparation Siopel® 50g
    13.02.02 Barrier preparation Cavilon® Obtain from central supplies not pharmacy
    24.16 BCG vaccination Neonatal
    14.04 BCG vaccine diagnostic agent Tuberculline Purified Protein Derivative (PPD)
    14.04 BCG vaccine Intradermal Bacillus Calmette-Guerin Vaccine
    03.02 Beclometasone Dipropionate Beclazone Easi-Breathe® 100 micrograms/dose, 250 micrograms/dose
    03.02 Beclometasone Dipropionate Clenil Modulite® 50 micrograms/dose, 100 micrograms/dose, 200 micrograms/dose, 250 micrograms/dose

    Prescribe by brand.
    Clenil Modulite is not interchangeable with other CFC-free inhalers.
    03.02 Beclometasone Dipropionate Qvar® 100 micrograms/dose Easi-breathe inhaler

    Prescribe by brand.
    Qvar is not interchangeable with other CFC-free inhalers.
    12.02.01 Beclometasone Dipropionate Beconase / Nasobec Aqueous nasal spray 50micrograms/spray
    24.01 Beclometasone inhaler 
    03.01 Beclometasone, Formoterol and Glycopyrronium Trimbow® Each metered dose (the dose leaving the valve) contains 100 micrograms of beclometasone dipropionate, 6 micrograms of formoterol fumarate dihydrate and 10 micrograms of glycopyrronium (as 12.5 micrograms glycopyrronium bromide).
    03.02 Beclometasone/formoterol Fostair® Aerosol inhaler (licensed for both asthma and COPD)
    NEXThaler® (licensed for asthma only)

    Beclomethasone 100 micrograms/
    formoterol 6 micrograms


    Equivalent to Seretide 125 and Symbicort 200/6.
    For initiation by respiratory specialists only.
    20 BENZBROMARONE Tablets 100 mg, 50mg  For patients intolerant to allopurinol and febuxostat only.
    03.08 Benzoin Tincture Compound BP Friar's Balsam
    13.06.01 Benzoyl Peroxide PanOxyl® Gel 2.5%, 10%
    13.06.01 Benzoyl Peroxide 5% with Clindamycin 1% Duac® Once Daily
    12.03.01 Benzydamine Difflam Oral rinse
    Spray
    24.01 Benzydamine oral spray 
    05.01.01.01 Benzylpenicillin  Injection 600mg & 1.2g powder
    24.01 Benzylpenicillin 
    24.16 Benzylpenicillin Neonatal
    04.06 Betahistine Dihydrochloride  Tablets 8mg
    11.04.01 Betamethasone  Eye drops 0.1%
    Eye ointment 0.1%
    13.04 Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic®
    13.04 Betamethasone (as Valerate) 0.025% Betnovate-RD®
    13.04 Betamethasone (as Valerate) 0.1% Betnovate®
    13.04 Betamethasone (as Valerate) 0.1% with Clioquinol Betnovate-C®
    13.04 Betamethasone (as Valerate) 0.1% with Fucidic Acid 2% Fucibet®
    11.04.01 Betamethasone 0.1% with Neomycin 0.5%  Eye drops
    Eye ointment

    Temporarily discontinued
    12.01.01 Betamethasone Sodium Phosphate  Ear/Ear/Nose drops 0.1%
    12.02.01 Betamethasone Sodium Phosphate 0.1%  Eye/Ear/Nose drops
    12.01.01 Betamethasone Sodium Phosphate 0.1% with Neomycin Sulphate 0.5%  Eye/Ear/Nose drops (betamethasone 0.1%/ neomycin 0.5%)
    11.06 Betaxolol Hydrochloride Betoptic® Eye drops 0.5%
    08.01.05 Bevacizumab Avastin®
    11.08.02 Bevacizumab Avastin® Intravitreal injection 1.25mg (Unlicensed)

    Initiation by Consultant Ophthalmologist only
    08.03.04.02 Bicalutamide Casodex®
    11.06 Bimatoprost Lumigan® Eye drops 300micrograms/ml
    This is been discontinued and unlikely to be available after August 2015
    11.06 Bimatoprost preservative-free  Lumigan UD ® For patients with hypersensitivity to preservatives

    Approved by HaRD APC May 2013
    11.06 Bimatoprost with Timolol Ganfort® Eye drops (Bimatoprost 300micrograms/ml & timolol 0.5%)

    Use only if patients are non-compliant with the two individual eye drops
    12.03.05 BioXtra® 
    06.01.01.02 Biphasic Insulin Aspart NovoMix® 30 Cartridge
    Flexpen
    06.01.01.02 Biphasic Insulin Lispro Humalog® Mix25 Cartridge
    Kwikpen
    06.01.01.02 Biphasic Insulin Lispro Humalog® Mix50 Cartridge
    Kwikpen
    06.01.01.02 Biphasic Isophane Insulin Humulin® M3 Cartridge
    Kwikpen
    01.06.02 Bisacodyl  Suppositories 5mg, 10mg
    First choice in primary care
    02.04 Bisoprolol Fumarate  Tablets 1.25mg, 2.5mg, 5mg
    First line in heart failure
    09.05.01.02 Bisphosphonates 
    08.01.02 Bleomycin 
    24.16 Blood Products Neonatal
  • Not pharmacy products - order from Blood Bank
  • 04.09.03 Botulinum Toxin Type A Botox® Injection 100units

    On the advice of a specialist.

    Prescribe by brand
    04.09.03 Botulinum Toxin Type A Dysport® Injection 500units

    Initiation on the advice of a specialist.

    Prescribe by brand
    04.09.03 Botulinum Toxin Type B NeuroBloc®
    01.06.05 Bowel Cleansing Solutions Moviprep® Approved by HaRD Area Prescribing Committee September 2013.

    13.06 Brimonidine 0.3% Gel Mirvaso® Brimonidine gel will not be effective in inflammatory rosacea i.e. it will not treat papules and pustules.

    Do not treat erythema associated with rosacea unless the inflammatory component is controlled. If the inflammatory component of rosacea is difficult to manage please refer to secondary care - do not treat with Brimonidine.

    Brimonidine will not be effective in a proportion of patients. The onset on action is less than an hour in most patients. HDFT Dermatologists practice is to give a test dose, and assess the patient at 1-2 hours. If Brimonidine treatment is judged to be effective by the clinician, it can be prescribed.

    The patient should be informed that increasing the topical dose to more than the five pea sized applications to the face once daily will NOT improve efficacy and is an off-licence use.

    Patients should be informed that the product can be used once daily, but it is acceptable to use on a PRN basis.

    Rebound erythema can occur 5-10 hours post dose which seems to be responsive to further application of Brimonidine (off licence use).
    Further studies are required to elucidate if this rebound is associated with any long term adverse events.
    11.06 Brinzolamide Azopt® Eye drops 10mg/ml
    11.06 Brinzolamide 1% with Timolol 0.5% (Azarga®)  Eye drops (Brinzolamide 10mg & timolol 0.5%)

    For use only if patients are non-compliant with the two individual eye drops
    11.06 Brinzolamide 10mg/ml & Brimonidine 2mg/ml Eye Drops Simbrinza® Approved by the Area Prescribing Committee, December 2014.
    04.08.01 Brivaracetam  Briviact® Initiation on the advice of a Neurologist
    01.05.02 Budesonide Budenofalk® MR Capsules 3mg
    03.02 Budesonide  Pulmicort®
    Easyhaler®
    03.01 Budesonide and Formoterol Fobumix®

    Each delivered dose (the dose that leaves the mouthpiece) contains: budesonide 160 micrograms/inhalation and formoterol fumarate dihydrate 4.5 micrograms/inhalation.

    03.02 Budesonide and formoterol Symbicort® Turbohaler budesonide 200micrograms/formoterol 6 micrograms per dose

    For initiation by repiratory specialists only
    24.01 Budesonide nebules 
    02.02.02 Bumetanide 
    15.02 Bupivacaine and Adrenaline 
    15.02 Bupivacaine Hydrochloride 
    15.02 Bupivacaine hydrochloride Marcain heavy®
    04.07.02 Buprenorphine BuTrans® Patches 5micrograms/hr, 10micrograms/hr,
    20micrograms/hr

    Once a week patch

    Initiation on the advice of a specialist
    04.07.02 Buprenorphine Temgesic® Sublingual tablets 0.4mg, 2mg

    04.07.02 Buprenorphine Transtec® Patches 35micrograms/hr, 52.5micrograms/hr,
    70micrograms/hr

    Change every 96 hours

    Initiation on the advice of a specialist
    04.10 Buprenorphine Subutex® Not stocked at HDFT

    Initiation on the advice of a Consultant Psychiatrist
    02.02.04 Burinex A®  Tablets amiloride/bumetanide 5/1mg
    08.01.01 Busulfan Myleran®
    04.09.01 Cabergoline  Tablets 500micrograms

    Initiation on the advice of a specialist
    06.07.01 Cabergoline Dostinex® Tablets 500micrograms

    Initiation on the advice of a specialist
    24.16 Caffeine citrate Neonatal
    13.03 Calamine  Lotion 200ml
    13.05.02 Calcipotriol Dovonex®
    13.05.02 Calcipotriol 50micrograms/g with Betamethasone 0.05% Dovobet® gel and ointment and Enstilar® cutaneous foam When prescribing Dovobet Gel, please prescribe "Dovobet Gel with Applicator". This aids administration to the scalp.

    Please note that NICE states that Dovobet is a 4th line topical in patients with mild psoriasis that are able to adhere to twice daily treatment.


    Topical treatment of psoriasis affecting the trunk and limbs

    1.3.2.1 Offer a potent corticosteroid applied once daily plus vitamin D or a vitamin D analogue applied once daily (applied separately, one in the morning and the other in the evening) for up to 4 weeks as initial treatment for adults with trunk or limb psoriasis.

    1.3.2.2 If once-daily application of a potent corticosteroid plus once-daily application of vitamin D or a vitamin D analogue does not result in clearance, near clearance or satisfactory control of trunk or limb psoriasis in adults after a maximum of 8 weeks[22], offer vitamin D or a vitamin D analogue alone applied twice daily.

    1.3.2.3 If twice-daily application of vitamin D or a vitamin D analogue does not result in clearance, near clearance or satisfactory control of trunk or limb psoriasis in adults after 8–12 weeks[22], offer either:
    a potent corticosteroid applied twice daily for up to 4 weeks or a coal tar preparation applied once or twice daily.

    1.3.2.4 If a twice-daily potent corticosteroid or coal tar preparation cannot be used or a once-daily preparation would improve adherence in adults offer a combined product containing calcipotriol monohydrate and betamethasone dipropionate applied once daily for up to 4 weeks.
    06.06.01 Calcitonin (salmon) / Salcatonin Miacalic® Injection 100 units/ml
    Initiation on the advice of a specialist
    13.05.02 Calcitriol 3micrograms/g Silkis®
    08.01 Calcium Folinate  Injection 50mg/5ml
    09.05.01.01 Calcium Salts Calcium Chloride Minijet 10% (6.8mmol/10ml)
    09.05.02.02 Calcium Salts Calcichew® Chewable tablets 1.25mg (500mg calcium)

    Initiation on the advice of a Renal Specialist
    09.05.02.02 Calcium Salts Phosex® Tablets 1g

    Initiation on the advice of a Renal Specialist
    06.01.02.03 Canagliflozin Invokana® Approved by the Area Prescribing Committee September 2014
    02.05.05.02 Candesartan Cilexetil Amias® Tablets 4mg 8mg 16mg
    20 Cantharadin, podophyllin and salicylic acid Cantherone Plus® Approved by HaRD Area Prescribing Committee April 2014 for an initial 3 month trial.
    To be initiated by Consultant Dermatologists only and used if all other treament options have failed.
    08.01.03 Capecitabine Xeloda®
    04.07.03 Capsacin  Cream 0.025%, 0.075%

    For initiation by a specialist
    10.03.02 Capsaicin Zacin® Cream 0.025%, 0.075%

    For use by specialist pain team only
    24.01 Captopril  Licensed liquid available
    04.07.03 Carbamazepine  Tablets 100mg, 200mg
    Liquid 100mg/5ml
    04.08.01 Carbamazepine  Tablets 100mg, 200mg
    MR tablets 200mg, 400mg
    Liquid 100mg/5ml
    Suppositories 125mg, 250mg

    Prescribe by brand
    24.01 Carbamazepine 
    06.02.02 Carbimazole Neo-Mercazole® Tablets 5mg, 20mg
    03.07 Carbocisteine  Capsules 375mg
    Liquid 250mg/5ml
    Stop after a 4 week trial if no benefit
    11.08.01 Carbomer 980 Xailin Gel® Eye drops 0.2%
    07.01.01 Carboprost Hemabate® Injection 250micrograms/ml
    11.08.01 Carmellose Sodium 0.5% Xailin Fresh®
    08.01.01 Carmustine BiCNU®
    24.16 Carobel Neonatal
    02.04 Carvedilol  Tablets 3.125mg, 6.25mg, 12.5mg
    For Consultant use only
    Second line in heart failure
    07.04.04 Catheter Patency Solutions Chlorhexidine 0.02%
    07.04.04 Catheter Patency Solutions Sodium Chloride 0.9%
    07.04.04 Catheter Patency Solutions Solution G
    05.01.02.01 Cefaclor  Liquid 250mg/5ml
    05.01.02.01 Cefalexin  Capsules 250mg & 500mg
    Liquid 250mg/5ml
    24.01 Cefalexin 
    05.01.02.01 Cefixime Suprax® Tablets 200mg
    Liquid 100mg/5ml
    05.01.02.01 Cefotaxime  Injection 500mg & 1g powder

    Formulary Indication:
    Meningitis

    For all other indications microbiology advice should be sought
    24.01 CefoTAXime 
    24.16 Cefotaxime Neonatal
  • Cefotaxime for any indication requires microbiology approval, including patients transferred to the unit where cefotaxime has already been initiated
  • 05.01.02.01 Ceftazidime  Injection 1g & 2g powder

    For use on microbiology advice ONLY

    Ceftazidime-Avibactam (Zaficefta) also approved for use on microbiology advice ONLY
    24.16 Ceftazidime Neonatal
    05.01.02.01 Ceftriaxone  Injection 1g Powder

    Paediatrics ONLY, unless recommended by a consultant microbiologist.
    24.01 CefTRIAXone 
    05.01.02.01 Cefuroxime  Injection 250mg, 750mg & 1.5g powder
    11.03.01 Cefuroxime   Intracameral injection 3mg
    24.01 CefUROXime 
    24.16 Cefuroxime Neonatal
    10.01.01 Celecoxib Celebrex® Capsules 100mg

    Initiation on the advice of a Consultant Rheumatologist only
    10.01.03 Certolizumab Pegol Cimzia®

    Initiation by a Consultant Rheumatologist

    03.04.01 Cetirizine   First-line at HDFT

    Tablets 10mg; Liquid 5mg/5ml
    24.01 Cetirizine 
    08.01.05 Cetuximab Erbitux®
    04.01.01 Chloral Hydrate  Liquid 500mg/5ml

    Unlicensed
    24.01 Chloral hydrate 
    20 CHLORAL HYDRATE mixture 1g/10ml 
    08.01.01 Chlorambucil Leukeran® Tablets 2mg
    05.01.07 Chloramphenicol  Eye drops (0.5%) & ointment (1%)
    Injection 1g

    Topical use for conjuctivitis
    11.03.01 Chloramphenicol  Eye drops 0.5%
    Eye ointment 1%
    Minims 0.5%
    24.16 Chloramphenicol Neonatal
    04.01.02 Chlordiazepoxide Hydrochloride  For alcohol detoxification only
    13.11.02 Chlorhexidine Gluconate 0.5% (Aqueous) 
    13.11.02 Chlorhexidine Gluconate 0.015% with Cetrimide 0.15% Tisept®
    13.11.02 Chlorhexidine Gluconate 4% Hydrex®
    13.11.02 Chlorhexidine Gluconate Solution 2.5% (≡ Chlorhexidine Gluconate 0.5%) (Alcoholic) 
    13.11.02 Chlorhexidine Gluconate Solution 5% (≡ Chlorhexidine Gluconate 1%) Hibitane Obstetric®
    12.02.03 Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin® Nasal cream

    Contains peanut oil
    12.03.02 Chlorhexidine Mouthwash  Mouthwash 0.2%

    Mint flavour
    24.16 Chlorothiazide Neonatal
    24.01 Chlorphenamine 
    03.04.01 Chlorphenamine Maleate  Tablets 4mg; Liquid 2mg/5ml; Injection 10mg/ml
    04.02.01 Chlorpromazine Hydrochloride  Tablets 10mg, 25mg, 50mg, 100mg
    Injection 50mg/2ml (hospital only)
    Liquid 100mg/5ml
    02.02.01 Chlortalidone 
    12.03.01 Choline Salicylate Bonjela® Adult
    08.02.02 Ciclosporin  Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand.
    10.01.03 Ciclosporin  Capsules 25mg, 50mg, 100mg

    Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand.
    13.05.03 Ciclosporin  Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand.
    11.08.01 Ciclosporin 1mg/mL Eye Drops Ikervis® Approved in line with NICE TA369
    09.05.01.02 Cinacalcet Mimpara® Tablets 30mg, 90mg

    For use by the Renal Unit only
    05.01.12 Ciprofloxacin  Tablets 250mg
    Infusion 200mg/100ml & 400mg/200ml (hospital only)

    Approved Indications:
    Complicated UTIs
    Pyelonephritis (2nd Line)
    Urinary Sepsis (2nd Line)
    Severe Salmonella/Campylobacter
    Severe Otitis Externa
    Prostatitis
    Human/Animal Bites

    Micobiology advice should be sought for all other indications
    08.01.05 Cisplatin 
    04.03.03 Citalopram  Tablets 10mg, 20mg
    Oral drops 40mg/ml (8 oral drops = 10mg tablet)
    01.06.05 Citrafleet® 
    20 Citric acid 0.6mol/5ml  Approved by HaRD APC for the assessment of laryngeal sensation via Cough Reflex Testing (CRT) in patients admitted with stroke with a known or suspected swallowing impairment
    08.01.03 Cladribine Litak®
    08.01.03 Cladribine 
    05.01.05 Clarithromycin  Tablets 250mg
    Liquid 125mg/5ml
    Injection 500mg powder (hospital only)
    24.01 Clarithromycin 
  • Oral - BNFc
  • IV - follow prescribing and administration guide
  • 24.16 Clarithromycin Neonatal
    05.01.06 Clindamycin  Capsules 150mg
    Liquid 75mg/5ml (Unlicensed)
    Injection 300mg/2ml
    24.01 Clindamycin  Suspension is unlicensed
    13.06.01 Clindamycin 1% Dalacin T®
    04.08.01 Clobazam  Tablets 10mg

    Initiation on the advice of a Neurologist
    13.04 Clobetasol Propionate 0.05% Dermovate® Cream 30g, 100g
    Ointment 30g, 100g
    13.04 Clobetasone Butyrate 0.05% Eumovate® Cream 30g
    Ointment 30g
    13.04 Clobetasone Butyrate 0.05%, Oxytetracycline 3%, Nystatin 100,000 units/g Trimovate®
    06.05.01 Clomifene Citrate Clomid® Tablets 50mg
    04.08.01 Clonazepam Rivotril® Tablets 500micrograms

    Initiation on the advice of a Neurologist
    04.08.02 Clonazepam Rivotril® Injection 1mg/ml
    24.01 Clonidine (growth hormone stimulation test) 
    02.09 Clopidogrel  Tablets 75mg
    07.02.02 Clotrimazole  Cream 1%
    Solution 1%
    Pessaries 200mg, 500mg
    12.01.01 Clotrimazole Canesten® Cream 1%
    13.10.02 Clotrimazole 
    04.02.01 Clozapine Clozaril® Tablets 25mg, 100mg

    Initiation by specialists only.
    Patients must be registered with Clozaril monitoring service.
    13.05.02 Coal Tar 10% Carbo-Dome®
    13.05.02 Coal Tar in Lassars Paste 
    13.05.02 Coal Tar Solution 12%, Salicylic Acid 2%, Precipitated Sulphur 4% Sebco®
    13.05.02 Coal Tar Solution 2.5%, Arachis (peanut) Oil extract of Coal Tar 7.5%, Tar 7.5%, Cade Oil 7.5%, Liqiud Paraffin 35% Polytar Emollient®
    02.02.04 Co-amilofruse (furosemide and amiloride)  Tablets amiloride/furosemide 2.5/20mg, 5/40mg
    05.01.01.03 Co-Amoxiclav  Tablets 375mg & 625mg
    Syrup 125/31mg & 250/62mg
    Injection 1.2g powder

    Should be prescribed as "Amoxicillin/Clavulanate" to identify it as a penicillin.

    Indications
    Animal/Human Bites
    Open fractures
    24.01 Co-amoxiclav 
  • Oral - follow BNFc
  • IV - follow dosing and administration guide
  • 24.16 Co-amoxiclav Neonatal
  • Oral dosing for chest infections in neonates without IV access (providing there have been no previous resistant gram negative bacteria isolated): dose as per BNFc (click icon to the left). When prescribed ensure the concentration (125/31) is clearly written on the prescription.
  • IV dosing on the recommendation of microbiology only: dose as per BNFc (click icon to the left), administration as per Paediatric Medusa IV Guide (see link below)
  • 04.09.01 Co-Beneldopa Madopar®CR
    04.09.01 Co-Beneldopa Madopar® Benserazide/levodopa
    Capsules 12.5/50, 25/100, 50/200
    Dispersible tablets 12.5/50, 25/100
    MR capsules 25/100
    15.02 Cocaine 
    04.09.01 Co-Careldopa Sinemet® CR
    04.09.01 Co-Careldopa Sinemet® Carbidopa/levodopa
    Tablets 10/100, 12.5/50, 25/100, 25/250
    MR tablets 25/100, 50/200

    04.09.01 Co-Careldopa Half Sinemet ®CR
    04.09.01 Co-Careldopa and Entacapone Sastravi®
    13.06.02 Co-Cyprindiol 2000/35
    (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms)
     Dianette®
    01.06.02 Co-danthramer  Suspension 25/200 in 5ml;
    Strong suspension 75/1000 in 5ml

    For palliative patients only
    01.06.02 Co-danthrusate  Capsules 50/60
    03.09.01 Codeine Linctus BP  Liquid 15mg/5ml
    01.04.02 Codeine Phosphate  Tablets 15mg 30mg
    04.07.02 Codeine Phosphate  Tablets 15mg, 30mg
    Liquid 15mg/5ml
    Injection 60mg/ml - CONTROLLED DRUG
    04.07.02 Codeine Phosphate Codeine Linctuses Liquid 15mg/5ml
    10.01.04 Colchicine  Tablets 500 micrograms
    24.16 Colecalciferol Neonatal 3000units/ml oral solution (unlicensed)
    09.06.04 Colecalciferol (vitamin D3) 
    09.06.04 Colecalciferol and Calcium Carbonate Adcal-D3®
    02.12 Colesevelam  Cholestagel® management of bile acid malabsorption
    01.09.02 Colestyramine  Sachets 4g
    05.01.07 Colistin Colomycin® Approved by the Area Prescribing Committee for non-cystic fibrosis bronchiectasis
    10.03.01 Collagenase clostridium histolyticum  Xiapex®
    13.10.05 Collodion Flexible BP 
    01.01.01 Co-magaldrox Maalox®
    07.03.01 Combined Hormonal Contraceptives Millinette20/75® Ethinylestradiol 20micrograms/gestodene 75 micrograms

    Approved by HaRD Area Prescribing Committee June 2014
    07.03.01 Combined Hormonal Contraceptives Mercilon/Gedarel 20/150® Tablets ethinyestradiol 20micrograms/ desogestrel 150micrograms
    07.03.01 Combined Hormonal Contraceptives Evra® Patch ethinylestradiol 33.9micrograms/24hours & norelgestromin 203micrograms/24hours
    07.03.01 Combined Hormonal Contraceptives Logynon® Tablets
    07.03.01 Combined Hormonal Contraceptives Microgynon 30® Rigevidon ® Levest® Tablets Ethinylestradiol 30micrograms/ levonorgestrel 150micrograms
    07.03.01 Combined Hormonal Contraceptives Cilest® Tablets ethinylestradiol 35micrograms, norgestimate 250micrograms
    07.03.01 Combined Hormonal Contraceptives Marvelon/Gedarel 30/150® Tablets ethinylestradiol 30micrograms/ desogestrel 150micrograms
    07.03.01 Combined Hormonal Contraceptives Yasmin® Lucette ® Tablets Ethinylestradiol 30micrograms/ drospirenone 3mg
    07.03.01 Combined Hormonal Contraceptives Femodene® Tablets Ethinylestradiol 30micrograms / gestodene 75micrograms
    06.01.06 Contour Black Edition meter 
    01.04.02 Co-Phenotrope Lomotil® Tablets
    05.01.08 Co-trimoxazole  (Trimethoprim/sulfamethoxazole)
    Tablets 480mg & 960mg
    Injection 480mg/5ml
    13.03 Crotamiton Eurax/Eurax HC® Cream 10% (30g)

    With hydrocortisone 2.5% (30g)
    04.06 Cyclizine  Tablets 50mg
    Injection 50mg/ml
    17 Cyclizine  Dose: 50mg s/c every 8 hours prn
    24.16 Cyclopentolate 0.5% eye drops Neonatal
    11.05 Cyclopentolate Hydrochloride  Eye drops 0.5%, 1%
    11.05 Cyclopentolate Hydrochloride single use Minims® Cyclopentolate Hydrochloride Eye drops 1%
    08.01.01 Cyclophosphamide  Tablets 50mg
    06.04.02 Cyproterone Acetate  Tablets 100mg

    Initiation on the advice of a specialist
    08.03.04.02 Cyproterone Acetate  Tablets 100mg
    08.01.03 Cytarabine 
    02.08.02 Dabigatran Pradaxa® See NICE guidance.
    NOAC of choice in patients requiring cardioversion.

    Dabigatran and edoxaban will be reserved for those who have a contra-indication to, or intolerant of rivaroxaban / apixaban or where the prescriber feels dabigatran or edoxaban would be the most appropriate agent.
    08.01.05 Dabrafenib Tafinlar® Patients are referred to Leeds Teaching Hospitals
    06.07.02 Danazol  Capsules 100mg, 200mg

    Initiation on the advice of a specialist
    10.02.02 Dantrolene Sodium Dantrium® Capsules 25mg, 100mg
    Injection 20mg
    15.01.08 Dantrolene Sodium Dantrium Intravenous®
    06.01.02.03 Dapagliflozin Forxiga®
    05.01.07 Daptomycin Cubicin® For use on microbiology advice ONLY
    08.01.05 Dasatinib Sprycel®
    08.01.02 Daunorubicin 
    09.01.03 Deferasirox Exjade® Dispersible tablets 125mg, 250mg, 500mg

    Initiation by Consultant Haematologist only
    09.01.03 Deferiprone Ferriprox® Tablets 500mg

    Initiation by Consultant Haematologist only
    08.03.04.02 Degarelix Firmagon® Approved by the Area Prescribing Committee, December 2014
    06.06.02 Denosumab Prolia® Initiation in accordance with shared care guidelines
    09.01.03 Desferrioxamine Mesilate Desferal® Injection 500mg
    15.01.02 Desflurane Suprane®
    06.05.02 Desmopressin  Tablets 200micrograms (Desmotabs)
    Nasal spray 10 micrograms/dose (Desmospray)
    Sublingual tablets 120 micrograms(Desmomelt)
    Intravenous injection 4 micrograms/mL
    Subcutanous injection 15 micrograms/mL (Octim)

    Initiation on the advice of a specialist
    24.01 Desmopressin 
    06.03.02 Dexamethasone  Tablets 500micrograms, 2mg

    Injection 3.3mg base(4mg/ml as sodium phosphate)
    Injection 6.6mg base (8mg/2ml as sodium phosphate)
    11.04.01 Dexamethasone Maxidex® Eye drops 0.1%
    11.04.01 Dexamethasone Minims® Dexamethasone Eye drops 0.1%
    11.04.02 Dexamethasone Ozurdex® Intra-vitreal implant 700micrograms

    24.01 Dexamethasone 
    24.16 Dexamethasone Neonatal
    12.01.01 Dexamethasone with Antibacterial Otomize® Ear spray (dexamethasone 0.1%, neomycin 3250 units/ml, glacial acetic acid 2%)
    11.04.01 Dexamethasone with Neomycin and Polymyxin B sulphate maxitrol® Eye drops
    17 Diamorphine  First choice opiate in normal renal function
    24.01 Diamorphine 
    04.07.02 Diamorphine Hydrochloride  Injection 5mg, 10mg, 30mg, 100mg
    Intranasal spray (Ayendi®)
    04.01.02 Diazepam  Tablets 2mg, 5mg, 10mg
    Liquid 2mg/5ml
    04.08.02 Diazepam  Rectal solution 5mg/2.5ml, 10mg/2.5ml
    Injection 10mg/2ml
    Emulsion injection 10mg/2ml
    04.08.03 Diazepam  Rectal solution 5mg/2.5ml, 10mg/2.5ml
    Injection 10mg/2ml (hospital only)
    10.02.02 Diazepam  Tablets 2mg, 5mg, 10mg
    Liquid 2mg/5ml
    24.01 Diazepam 
    10.01.01 Diclofenac Sodium  Tablets EC 25mg, 50mg
    MR tablets 75mg, 100mg
    Dispersible tablets 50mg
    Suppositories 12.5mg, 50mg, 100mg
    Gel 1%
    10.01.01 Diclofenac Sodium Voltarol® Injection 75mg/3ml
    13.08.01 Diclofenac Sodium Solaraze®
    08.03.01 Diethylstilbestrol 
    24.01 Diethylstilboestrol (pre-pubertal priming)  See individual protocols for clonidine and glucagon stimulation tests
    02.01.01 Digibind 
    02.01.01 Digoxin 
    04.07.02 Dihydrocodeine Tartrate  Tablets 30mg
    Liquid 10mg/5ml
    Injection 50mg/ml - CONTROLLED DRUG
    01.07.04 Diltiazem Cream 2%  Unlicensed
    02.06.02 Diltiazem Hydrochloride Tildiem® MR tablets (SR) 60mg, 90mg, 120mg
    (twice daily dosing)

    MR capsules (LA) 200mg, 300mg
    (once daily dosing)

    Prescribe by brand
    02.06.02 Diltiazem Hydrochloride Adizem® SR Capsules 90mg, 120mg, 180mg
    (twice daily dosing)

    XL Capsules 120mg, 180mg, 240mg, 300mg
    (once daily dosing)

    Prescribe by brand
    02.06.02 Diltiazem Hydrochloride Adizem-SR® MR Capsules 90mg, 120mg, 180mg

    Prescribe by brand
    02.06.02 Diltiazem Hydrochloride Dilzem® SR MR Capsules (SR) 60mg
    (twice daily dosing)

    Prescribe by brand
    13.05.02 Dimethyl Fumarate Skilarence®
    20 DIMETHYL SULPHOXIDE Bladder Instillation 50% 
    13.10.04 Dimeticone Hedrin®
    07.01.01 Dinoprostone Prostin E2® Vaginal gel 1mg/2.5ml, 2mg/2.5ml
    Extra-amniotic solution 5mg/0.5ml
    07.01.01 Dinoprostone Propess® Pessaries 10mg
    14.04 Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) and Haemophilus Type b Conjugate Vaccine (Adsorbed), Hepatitis B (Infanrix Hexa®) 
    24.16 Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) and Haemophilus Type b Conjugate Vaccine (Adsorbed), Hepatitis B (Infanrix Hexa®) Neonatal
    02.09 Dipyridamole Persantin® Retard MR capsules 200mg
    02.09 Dipyridamole and Aspirin Asasantin® Retard MR capsules aspirin/dipyridamole 25/200mg
    06.06.02 Disodium Pamidronate  Injection 30mg
    02.03.02 Disopyramide  MR Tablets 250mg; Capsules 100mg;
    Injection 50mg/5ml (hospital only)
    04.10 Disulfiram Antabuse® Tablets 200mg

    Initiation on the advice of a Psychiatrist
    13.05.02 Dithranol Dithrocream®
    20 DITHRANOL 0.1% /0.25%,0.5%,1%,2%,4%in lassars paste 
    02.07.01 Dobutamine  Injection 250mg/20ml
    24.01 Dobutamine 
    24.16 Dobutamine Neonatal
    04.06 Domperidone  Tablets 30mg
    Liquid 5mg/5ml
    Suppositories 30mg
    04.11 Donepezil Hydrochloride Aricept® Tablets 5mg, 10mg

    Initiation on the advice of a specialist
    24.01 Dopamine 
    24.16 Dopamine Neonatal
    02.07.01 Dopamine Hydrochloride  Injection 200mg/5ml, 800mg/20ml
    03.07 Dornase Alfa Pulmozyme® Nebuliser solution 2.5mg/2.5ml

    For cystic fibrosis patients only
    11.06 Dorzolomide Trusopt® Eye drops 2%
    11.06 Dorzolomide 2% with Timolol 0.5% Cosopt® Eye drops (Dorzolamide 2% & timolol 0.5%)
    15.01.07 Doxapram Hydrochloride Dopram®
    02.05.04 Doxazosin  Tablets 1mg, 2mg, 4mg
    13.04 Doxepin Hydrochloride Xepin®
    08.01.02 Doxorubicin Hydrochloride 
    05.01.03 Doxycycline  Capsules 100mg
    Dispersible tablets 100mg
    12.03.01 Doxycycline 
    12.03.02 Doxycycline  Dispersible tablets 100mg (unlicensed indication)

    Use as a mouthwash (third line option after chlorhexidine mouthwash and betamethasone soluble tablets used as a mouthwash)
    02.03.02 Dronedarone Multaq® For use by Cardiology Specialists only if intolerant to amiodarone
    04.06 Droperidol Xomolix® Injection 2.5mg/ml

    On the advice of a specialist
    03.01.05 Drug Delivery Device Haleraid® 120 dose, 200 dose
    03.01.05 Drug Delivery Device Volumatic® Standard
    Standard with mask
    03.01.05 Drug Delivery Device AeroChamber® Child with mask (yellow)
    Infant with mask (orange)
    Standard (blue)
    Standard with mask (blue)
    06.01.02.03 Dulaglutide  Trulicity® Approved by the Area Prescribing Committee (July 2015) in line with NICE criteria.

    Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
    04.03.04 Duloxetine Cymbalta® Capsules 30mg, 60mg

    Only on the advice of a specialist.
    Specify brand
    13.05.03 Dupilumab Dupixent® For use by Consultant Dermatologists only - for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy.
    02.08.02 Edoxaban Lixiana® Dabigatran and edoxaban will be reserved for those who have a contra-indication to, or intolerant of rivaroxaban / apixaban or where the prescriber feels dabigatran or edoxaban would be the most appropriate agent.
    10.02.01 Edrophonium Chloride  Injection 10mg/ml
    15.01.06 Edrophonium Chloride 
    13.09 Eflornithine Vaniqa®

    For Dermatology and Endocrinology

    24.16 Elfin Trial Neonatal
    09.01.04 Eltrombopag Revolade® Approved in line with NICE TA293
    01.04.02 Eluxadoline Truberzi
    13.02.01.01 Emollient Bath Additive Oilatum® Gel 150g
    Oilatum Plus bath 500ml
    13.02.01.01 Emollient Bath Additive E45®
    13.02.01.01 Emollient Bath Additive with Anitmicrobials Dermol® 600ml
    13.02.01 Emollient preparation Cetraben®
    13.02.01 Emollient preparation Zerobase®

    Tube 50g
    Pump dispenser 500g

    Other brands include Diprobase

     

    13.02.01 Emollient preparation Zeroderm® Ointment 500g
    13.02.01 Emollient preparation Zerocream/E45® 50g
    13.02.01 Emollient preparation containing Urea 10% Flexitol® Flexitol or cheapest equivalent
    13.02.01 Emollient preparation containing Urea 5% Imuderm®
    13.02.01 Emollient preparation with antimicrobials Dermol® Lotion 500ml
    06.01.02.03 Empagliflozin Jardiance® Approved by the HaRD Area Prescribing Committee, April 2015, in line with NICE TA336
    02.08.01 Enoxaparin Sodium 100mg in 1mL and 150mg in 1mL Pre-filled syringe 20mg, 40mg, 60mg, 80mg, 100mg, 120mg, 150mg

    For therapeutic dosing when CrCl is <30ml/min
    04.09.01 Entacapone Comtess® Tablets 200mg
    08.03.04.02 Enzalutamide Xtandi®
    12.02.02 Ephedrine Hydrochloride  Nose drops 0.5%
    02.07.02 Ephedrine Hydrocloride  Injection 30mg/ml; Pre-filled syringe 30mg/10ml
    08.01.02 Epirubicin hydrochloride 
    02.02.03 Eplerenone Inspra® Initiation by Cardiology specialists only.

    Patients to be switched to spironolactone 25mg daily by GP after 28 days of treatment with eplerenone.

    09.01.03 Epoetin alfa Eprex®
    02.09 Eptifibatide Integrilin® Injection 20mg/10ml
    Infusion 75mg/100ml
    09.06.04 Ergocalciferol  Injection 300,000 units
    07.01.01 Ergometrine Maleate Ergometrine Injection 500micrograms/ml
    07.01.01 Ergometrine Maleate and Oxytocin Syntometrine® Injection ergometrine 500micrograms & oxytocin 5units/ml
    08.01.05 Erlotinib Tarceva®
    05.01.02.02 Ertapenem Invanz® Microbiology advice only
    05.01.05 Erythromycin  Tablets 250mg

    24.01 Erythromycin 
    24.16 Erythromycin Neonatal
  • Oral dose and administration (GORD): BNF-c
  • 13.06.01 Erythromycin 40mg with Zinc Acetate 12mg/mL Zineryt®
    02.04 Esmolol Hydrochloride Brevibloc® Injection 10mg/ml
    10.01.03 Etanercept Enbrel®

    Initiation by Consultant Rheumatologists only

    10.01.03 Etanercept Benepali

    Initiated by consultant rheumatologist or dermatologist only.

    06.06.01 Etelcalcetide Parsabiv
    05.01.09 Ethambutol Hydrochloride Ethambutol®
    02.13 Ethanolamine Oleate  Injection 5%
    04.08.01 Ethosuximide  On specialist recommendation only in line with NICE guidance
    15.02 Ethyl Chloride Cryogesic® Spray
    15.01.01 Etomidate Hypnomidate®
    08.01.04 Etoposide 
    10.01.01 Etoricoxib Arcoxia® Tablets 30mg, 60mg, 90mg

    Initiation on the advice of a Consultant Rheumatologist only
    20.01 Evolocumab Repatha® Secondary prevention high risk/ v high risk with LDL above 4 and in primary prevention (FH) with LDL > 5
    08.03.04.01 Exemestane Aromasin® Tablets 25mg
    06.01.02.03 Exenatide Byetta® Pre-filled pen 5-micrograms/dose, 10micrograms/dose

    Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
    06.01.02.03 Exenatide Prolonged Release Bydureon® Injection 2mg

    Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).

    For use in patients with compliance problems with daily injections.
    02.12 Ezetimibe Ezetrol® Tablets 10mg

    10.01.04 Febuxostat Adenuric® Tablets 80mg
    02.12 Fenofibrate  Tablets 160mg
    04.07.02 Fentanyl  Patches 12micrograms/hr, 25micrograms/hr,
    50micrograms/hr, 75micrograms/hr, 100micrograms/hr

    Mezolar is the preferred brand patch in primary care.


    Injection 100micrograms/2ml, 500micograms/10ml Hodspital only).

    Nasal spray (PecFent) approved as a Green Drug for patients who have failed all other options.
    15.01.04.03 Fentanyl 
    24.01 Fentanyl 
    24.16 Fentanyl Neonatal 10microgram/ml injection (unlicensed)
    09.01.01.01 Ferrous Fumarate Fersaday® Tablets 322mg (100mg iron)

    Formulary switch from ferrous sulphate
    05.01.07 Fidaxomicin  DIFICLIR® Approved for use after recommendation from Microbiology
    09.01.06 Filgrastim Zarzio® Pre-filled syringe
    300 micrograms/0.5ml
    480 micrograms/0.5ml
    06.04.02 Finasteride Proscar® Tablets 5mg

    02.03.02 Flecainide Acetate  Tablets 100mg; Injection 150mg/5ml (hospital only)
    13.04 Flucinolone Acetonide 0.0025% Synalar 1 in 10 Dilution®
    13.04 Flucinolone Acetonide 0.00625% Synalar 1 in 4 Dilution®
    13.04 Flucinolone Acetonide 0.025% Synalar®
    05.01.01.02 Flucloxacillin  Capsules 250mg & 500mg
    Syrup 125mg/ml & 250mg/5ml
    Injection 500mg & 1g powder
    24.01 Flucloxacillin 
  • Oral - follow BNFc
  • IV - follow dosing and administration guide
  • 24.16 Flucloxacillin Neonatal
    07.02.02 Fluconazole  Capsules 50mg
    Suspension 50mg/5ml
    24.01 Fluconazole 
    24.16 Fluconazole Neonatal
    08.01.03 Fludarabine Phosphate Fludara®
    06.03.01 Fludrocortisone Acetate Florinef® Tablets 100micrograms
    13.04 Fludroxycortide  Haelan®
    24.01 Fluids intravenous 
    24.16 Fluids intravenous Neonatal
  • 'Standard' solutions containing calcium are no longer used
  • 15.01.07 Flumazenil 
    24.16 Flumazenil Neonatal
    12.01.01 Flumetasone Pivalate 0.02% with Clioquinol 1% Locorten-Vioform® Ear drops
    11.04.01 Fluocinolone acetonide Iluvien ® Intravitreal implant
    Approved by HaRD Area Prescribing Committee (APC) February 2014 in line with NICE guidance
    11.08.02 Fluorescein Sodium Minims® Minims 2%
    11.04.01 Fluorometholone FML® Eye drops Fluorometholone 0.1% & Polyvinyl alcohol 1.4%
    08.01.03 Fluorouracil 
    13.08.01 Fluorouracil Efudix®
    04.03.03 Fluoxetine  Capsules 20mg
    Liquid 20mg/5ml
    04.02.02 Flupentixol Decanoate Depixol® Injection 12.5mg/0.5ml, 20mg/ml, 25mg/ml, 40mg/2ml, 50mg/0.5ml, 100mg/ml
    04.02.02 Fluphenazine Decanoate  Injection 50mg/0.5ml, 100mg/ml
    08.03.04.02 Flutamide 
    03.02 Fluticasone and formeterol Flutiform Metered dose inhaler
    03.02 Fluticasone and salmeterol Sirdupla® Accuhaler (dry powder inhaler)
    -fluticasone 100 micrograms/salmeterol
    -fluticasone 250 micrograms/salmeterol
    -fluticasone 500 micrograms/salmeterol
    Evohaler (metered dose inhaler)
    -fluticasone 50 micrograms/salmeterol
    -fluticasone 125 micrograms/salmeterol
    -fluticasone 250 micrograms/salmeterol

    Please note that the Seretide brand of inhalers are only approved for use in children.
    12.02.01 Fluticasone furoate Avamys® Nasal spray 27.5micrograms/metered spray

    Initiation by ENT and Respiratory Consultants only.
    03.01 fluticasone furoate, umeclidinium bromide and vilanterol  Trelegy Ellipta ®

    Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms fluticasone furoate, 65 micrograms umeclidinium bromide equivalent to 55 micrograms umeclidinium and 22 micrograms vilanterol (as trifenatate). 

    12.02.01 Fluticasone Propionate Flixonase/Nasofan® Aqueous nasal spray 50micrograms/metered spray
    03.02 Fluticasone/Vilanterol  Relvar Ellipta® Relvar Ellipta 92 micrograms/22 micrograms inhalation powder
    03.02 Fluticasone/Vilanterol  Relvar Ellipta® Relvar Ellipta 184 micrograms/22 micrograms inhalation powder
    09.01.02 Folic Acid  Tablets 5mg
    Liquid 2.5mg/5ml
    24.16 Folic acid Neonatal 2.5mg/5ml liquid
    02.08.01 Fondaparinux Sodium Arixtra® Pre-filled syringe 5mg/ml

    For use in acute coronary syndromes
    03.01.04 Formoterol / aclidinium Duaklir® Genuair Licensed for COPD only
    03.01.01.01 Formoterol Fumarate Easyhaler® 12 micrograms/metered inhalation
    04.06 Fosaprepitant Ivemend® Injection 150mg

    Prescribed on the advice of a specialist only pre-chemotherapy
    20 Fosfomycin 2g Injection Fomicyt® Approved by the HaRD Area Prescribing Committee, April 2015.
    To be prescribed on the advice of Microbiology only.
    20 FOSFOMYCIN Sachets 3 g  Initiation on the advice of a Microbiologist
    06.01.06 FreeStyle Optium Neo Meter 
    02.11 Fresh Frozen Plasma  Available from Haematology
    08.03.04.01 Fulvestrant Faslodex® Injection 50mg/ml
    02.02.02 Furosemide  Long-term supply problem with furosemide 500mg - switch to bumetanide
    24.01 Furosemide 
    24.16 Furosemide Neonatal
    11.03.01 Fusidic Acid Fucithalmic® Eye drops MR 1%
    13.10.01.02 Fusidic Acid 2% Fucidin®
    04.07.03 Gabapentin  Capsules 100mg, 300mg, 400mg
    Liquid 250mg/5ml - reserve for patients with long-term swallowing difficulty or long-term feeding tubes.
    04.08.01 Gabapentin  Capsules 100mg, 300mg, 400mg
    04.11 Galantamine Reminyl® XL MR capsules 8mg, 16mg, 24mg

    Initiation on the advice of a specialist for patients intolerant to donepezil.

    MR formulation for patients non-compliant with standard release formulation.
    04.11 Galantamine  Tablets 12mg
    Liquid 4mg/ml

    Initiation on the advice of a specialist for patients intolerant to donepezil
    01.01.02 Gaviscon Infant  Sachets
    08.01.05 Gefitinib Iressa®
    08.01.03 Gemcitabine Gemzar®
    07.01.01 Gemeprost  Pessary 1mg

    For miscarriage if mifepristone & misoprostol have failed. Discuss with Consultant in Obs&Gynae before prescribing.
    05.01.04 Gentamicin  Injection 20mg/2ml & 80mg/2ml
    11.03.01 Gentamicin  Eye drops 0.3%
    24.01 Gentamicin 
    24.16 Gentamicin Neonatal
    12.01.01 Gentamicin 0.3% with Hydrocortisone Acetate 1% Gentisone® HC
    01.07.01 Germaloids®  Cream; Ointment; Suppositories
    12.03.05 Glandosane®  Aerosol spray
    06.01.02.01 Glibenclamide  Tablets 2.5mg, 5mg

    Initiation on the advice of a specialist
    06.01.02.01 Gliclazide  Tablets 80mg

    MR tablets 30mg - Initiation on the advice of a specialist.


    NB: Gliclazide and gliclazide MR doses are not bioequivalent. Contact a diabetes specialist for advice
    06.01.02.01 Glimepiride  Tablets 1mg

    Initiation on the advice of a specialist
    06.01.04 Glucagon GlucaGen® HypoKit Injection 1mg
    24.01 Glucagon 
    06.01.04 Glucojuice Glucojuice Approved by the Area Prescribing Committee March 2017
    06.01.06 GlucoMen LX beta-ketone 
    06.01.06 GlucoMen LX Plus meter 
    06.01.06 GlucoRx HCT & Ketone meter 
    06.01.06 GlucoRx Nexus meter 
    06.01.04 Glucose  Tablets
    Injection 50%
    06.01.04 Glucose gel Glucogel Oral gel 40% (3x25g)
    09.02.02.01 Glucose Intravenous  5% (100ml, 250ml, 500ml, 1000ml))
    10% (500ml)
    12.5% (250ml)
    15% (500ml)
    20% (500ml)
    50% (500ml)
    06.01.06 GluNeo meter 
    01.06.02 Glycerol (Glycerin)  Suppositories 1g 2g 4g
    02.06.01 Glyceryl Trinitrate  Spray 400micrograms/dose; Buccal tablets 2mg, 3mg, 5mg; Sublingual tablets 500micrograms; Injection 50mg/50ml (hospital only)
    20 Glyceryl Trinitrate 0.4% Ointment Rectogesic® Approved by HaRD APC March 2017 for chondrodermatitis
    07.04.04 Glycine  Irrigation solution 1.5% 3L
    13.12 Glycopyrronium Bromide 
    15.01.03 Glycopyrronium Bromide (Glycopyrrolate) Robinul®
    01.05.03 Golimumab Simponi
    06.07.02 Goserelin  Injection 3.6mg, 10.8mg

    Initiation on the advice of a specialist
    Not stocked at HDFT
    08.03.04.01 Goserelin Zoladex® Implant 3.6mg
    08.03.04.02 Goserelin Zoladex®
    04.06 Granisetron 3.1mg/24 hour patches Sancuso® Approved for an initial 6 month trial.
    Usage to be reviewed by the Area Prescribing Committee in July 2014
    03.04.02 Grass and Tree Pollen Extract Pollinex® For immunotherapy Consultant use only
    03.04.02 Grass pollen extract Grazax® For immunotherapy Consultant use only
    14.04 Haemophilus influenzae type B 
    04.02.01 Haloperidol  Tablets 1.5mg, 5mg, 10mg, 20mg
    Capsules 500 micrograms
    Liquid 2mg/ml
    Injection 5mg/ml
    04.02.02 Haloperidol Haldol Decanoate® Injection 50mg/ml, 100mg/ml
    17 Haloperidol  Dose: 0.5mg - 2.5mg s/c every 6 hours prn max 10mg/24hrs
    13.02.01 Heel Balm (Urea 25%) Flexitol® Approved by HaRD Area Prescribing Committee June 2017.

    Initiated in the diabetic foot clinic only.
    Treatment stopped after 4 weeks if no benefit observed.
    24.01 Heparin (unfractionated) 
    24.16 Heparinised saline Neonatal
    13.13 Heparinoid 0.3% Hirudoid®
    14.04 Hepatitis A vaccine 
    14.05.02 Hepatitis B immunoglobulin 
    14.04 Hepatitis B vaccine 
    24.16 Hepatitis B vaccine and immunoglobulin Neonatal
  • Dose: BNF-c
  • 20 HRH Cream Pigmanorm® Approved by the Area Prescribing Committee, April 2016
    Prescriptions for all other strengths of HRH should be queried; agreed in Dermatology Quality of Care to only prescribe and dispense the 5% Pigmanorm preparation
    09.02.02.02 Human Albumin Solution  Obtain from Haematology
    10.03.01 Hyaluronidase Hyalase® Injection 1500 units
    02.05.01 Hydralazine Hydrochloride  Injection 20mg
    01.05.02 Hydrocortisone Colifoam® 125mg /metered application
    06.03.02 Hydrocortisone Hydrocortisab® Hydrocortisone acetate 25mg/ml injection
    06.03.02 Hydrocortisone Solu-Cortef® Hydrocortisone sodium succinate 100mg injection
    13.04 Hydrocortisone 
    24.16 Hydrocortisone Neonatal
    13.04 Hydrocortisone 0.25% Crotamiton 10% Eurax-Hydrocortisone®
    13.04 Hydrocortisone 0.5%, nystation 100,000 units/g
    Benzalkonium Chloride Solution 0.2%, Dimeticone 350 10%
     Timodine®
    13.04 Hydrocortisone 1% with Clotrimazole 1% Canesten HC®
    13.04 Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort®
    10.01.02.02 Hydrocortisone acetate Hydrocortistab® Injection 25mg/ml
    13.04 Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H®
    12.01.01 Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone® HC Eye/Ear drops

    24.01 Hydrocortisone cream/ointment 
    24.01 Hydrocortisone injection 
    13.11.06 Hydrogen Peroxide Crystacide®
    20 Hydroquinone 4% cream  Approved for one patient only, May 2016
    09.01.02 Hydroxocobalamin  Injection 1mg/ml
    08.01.05 Hydroxycarbamide 
    10.01.03 Hydroxychloroquine Sulphate Plaquenil® Tablets 200mg
    03.04.01 Hydroxyine Hydrochloride Atarax® Tablets 10mg, 25mg
    03.04.01 Hydroxyine Hydrochloride Ucerax® 10mg/5ml syrup
    Note tablets are blacklisted.
    06.04.01.02 Hydroxyprogesterone Unlicensed Injection 250mg/ml

    Unlicensed medicine
    Initiation on the advice of a Consultant in Obs&Gynae
    20 HYDROXYPROGESTERONE 250mg/ml inj   For use by Consultants in Obstetrics only
    01.02 Hyoscine Butylbromide Buscopan® 10mg tablets; 20mg/ml injection
    17 Hyoscine butylbromide 
    24.01 Hyoscine butylbromide 
    03.07 Hypertonic Saline 7% Nebules Nebusal® Approved by the HaRD Area Prescribing Committee, January 2015
    11.08.01 Hypromellose  Eye drops 0.3%
    06.06.02 Ibandronic Acid  50mg tablets.
    (Note 150mg tablets remain non formulary)
    06.06.02 Ibandronic Acid Bonviva® Pre-filled syringe 3mg

    Initiation on the advice of a specialist
    08.01.05 Ibrutinib Imbruvica® Approved under the Cancer Drugs Fund, February 2015.

    Available in 90 and 120 capsule pack-sizes
    10.01.01 Ibuprofen  Tablets 200mg, 400mg
    Liquid 100mg/5ml
    Gel 5% (50g)
    24.01 Ibuprofen 
    24.16 Ibuprofen Neonatal
    20.01 Idelalisib 100mg and 150mg tablets Zydelig® Approved by the Area Prescribing Committee, November 2014
    08.01.01 Ifosfamide Mitoxana®
    13.07 Imiquimod Aldara®
    24.16 Immunisations Neonatal
    24.01 Immunoglobulins 
    24.16 Immunoglobulins Neonatal
  • To request immunoglobulin, a clinician request form (see link below) needs to be completed before discussion with pharmacy
  • 02.02.01 Indapamide 
    10.01.01 Indometacin  Capsules 25mg, 50mg
    MR tablets 75mg
    01.05.03 Infliximab Remicade® Consultant request only
    10.01.03 Infliximab Remicade® Initiation on the advice of a specialist
    14.04 Influenza vaccine  
    13.08.01 Ingenol mebutate gel Picato® Approved by HaRD APC April 2013.

    Not stocked at HDH.
    06.01.01.03 Injection devices Clikstar For glargine and glulisine cartridges
    06.01.01.03 Injection Devices HumaPen® Luxura
    06.01.01.03 Injection Devices NovoPen®
    06.01.01.01 Insulin Actrapid® Vial

    For use in the treatment of hyperkalaemia only
    06.01.01.01 Insulin Humulin® S Cartridge
    Vial
    24.16 Insulin Neonatal 50units in 50ml pre-filled syringe
    06.01.01.01 Insulin Aspart NovoRapid® Vial
    Cartridge
    Flexpen
    06.01.01.01 Insulin Aspart Fiasp® Vial
    Cartridge
    Flexpen

    Individual patient request through APC
    24.01 Insulin aspart (Novorapid) 
    06.01.01.02 Insulin Degludec Tresiba®
    24.01 Insulin degludec (Tresiba) 
    06.01.02.03 Insulin Degludec 100iu/mL and Liraglutide 3.6mg/mL Xultophy® Approved by the Area Prescribing Committee for secondary care use only November 2015.
    06.01.01.02 Insulin Detemir Levemir® Cartridge
    Flexpen

    Long acting insulin analogue of choice for management of type 1 diabetes.
    24.01 Insulin detemir (Levemir) 
    24.01 Insulin glargine (Abasaglar) 
  • Oral - follow BNFc
  • IV - follow prescribing and administration guide
  • 06.01.01.02 Insulin Glargine 100units/ml Lantus Prescribe by Brand
    No longer recommended for new patients.
    Abasaglar is the brand of choice if insulin glargine is required.
    06.01.01.02 Insulin Glargine 100units/ml (biosimilar) Abasaglar Cartridge
    kwikpen

    Abasaglar has been shown to be equivalent to Lantus in its pharmacokinetic and pharmacodynamic properties. However, as with other biosimilar medicines, some dose adjustment may be needed for some patients.


    Biosimilar insulin glargine approved for use in place of Lantus.
    06.01.01.01 Insulin Lispro  Humalog® Vial
    Cartridge
    Kwikpen
    24.01 Insulin lispro (Humalog) 
    09.03 Intralipid 20%  500ml
    07.03.04 Intra-uterine Contraceptive Devices Flexi-T® + 300
    07.04.04 Intravesical chondrotin & sodium hyaluronate bladder instillation iAluRil® Approved by HaRD Area Prescribing Committee June 2014
    06.02.02 Iodine and Iodide Aqueous Iodine Oral Solution Aqueous solution (Lugol's iodine)
    24.01 Ipratropium 
    03.01.02 Ipratropium Bromide  Inhaler 20mcg/dose
    Nebules 250mcg/ml, 500mcg/2ml
    12.02.02 Ipratropium Bromide Rinatec® Nasal spray 0.03%
    02.05.05.02 Irbesartan Aprovel ® Tablets 75mg 150mg
    For use by specilaists only for diabetic nephropathy
    09.01.01.01 Iron and Folic Acid Pregaday® Tablets 100mg iron & 350micrograms folic acid
    09.01.01.02 Iron Dextran CosmoFer® Injection 50mg/ml

    Initiation on the advice of a Haematologist

    Use pre-printed chart
    09.01.01.02 Iron Isomaltoside Monofer®

     

    100 mg/ml solution for injection/infusion.

    Refer to IV Iron Policy

    09.01.01.02 Iron Sucrose Venofer Injection 20mg/ml

    Use pre-printed chart
    15.01.02 Isoflurane 
    24.16 Isoniazid Neonatal
  • For treatment of congenital tuberculosis see BNFc
  • 06.01.01.02 Isophane Insulin Pork Hypurin® Cartridge
    06.01.01.02 Isophane Insulin Insulatard® Cartridge
    Innolet pen
    06.01.01.02 Isophane Insulin Humulin® I Cartridge
    Kwikpen
    02.07.01 Isoprenaline Sulphate Unlicensed Medicine Stock kept on ITU only
    02.06.01 Isosorbide Dinitrate  Injection 10mg/10ml
    For use in Cardiac Unit only
    02.06.01 Isosorbide Mononitrate  Tablets 10mg, 20mg; MR tablets 40mg, 60mg;
    MR capsules 25mg, 50mg
    13.06.01 Isotretinoin Isotrex®
    13.06.02 Isotretinoin 
    01.06.01 Ispaghula Husk  Sachets 3.5g
    02.06.03 Ivabradine Procoralan® Tablets 5mg

    For use by Cardiologists only.
    For rate-control when beta-blockers and calcium channel blockers are contra-indicated, in accordance with NICE guidance (see below).
    20.01 Ivermectin 10mg/g cream Soolantra® Apply daily and discontinue after 3 months if there is no response.
    To be used as a third-line treatment option (when Azelaic acid and metronidazole has failed).
    20.01 Ixekizumab 80mg solution for injection Taltz® Approved by the Area Prescribing Committee, January 2017
    15.01.01 Ketamine Ketalar®
    13.09 Ketoconazole 
    06.01.06 Ketones Ketostix®
    01.06.05 Klean-Prep® 
    02.04 Labetalol Hydrochloride  Tablets 100mg, 200mg;
    Injection 100mg/20ml (hospital only)
    04.08.01 Lacosamide  Vimpat ® Tablets 50mg

    Initiation on the advice of a specialist
    01.06.04 Lactulose  For alcohol induced encephalopathy only
    24.01 Lactulose  
    04.08.01 Lamotrigine  Tablets 25mg, 50mg, 100mg, 200mg
    Dispersible tablets 5mg, 25mg

    Initiation on the advice of a Neurologist
    01.03.05 Lansoprazole  Capsules 15mg 30mg;

    01.03.05 Lansoprazole  FasTabs 15mg 30mg for administration down enteral feeding tubes only
    24.01 Lansoprazole 
    09.05.02.02 Lanthanum Fosrenol ® Chewable tablets 500mg, 750mg

    Initiation on the advice of a Renal Specialist
    11.06 Latanoprost Xalatan® Eye drops 50micrograms/ml
    11.06 Latanoprost 0.005% with Timolol 0.5% Xalacom® Eye drops (latanoprost 50micrograms/ml & timolol 0.5%)
    10.01.03 Leflunomide Arava® Tablets 10mg
    08.02.04 Lenalidomide Revlimid® Patient authorisation form must be sent with each prescription

    Capsules 10mg, 15mg, 25mg
    08.03.04.01 Letrozole Femara® Tablets 2.5mg
    06.07.02 Leuprorelin Acetate Prostap® Injection 3.75mg, 11.25mg

    Approved in line with Leeds shared care guidelines in March 2014 for the initiation on the advice of a specialist.
    Not stocked at HDFT
    04.08.01 Levetiracetam Keppra® Tablets 250mg, 500mg, 1000mg
    Liquid 500mg/5ml
    Infusion 500mg/5ml

    Initiation on the advice of a Neurologist
    24.01 Levetiracetam 
    15.02 Levobupivacaine Chirocaine®
    15.02 Levobupivacaine with Fentanyl 
    05.01.12 Levofloxacin Tavanic®
    11.03.01 levofloxacin Oftaquix® Eye drops 0.5%
    17 Levomepromazine  Dose for agitation/distress: 25mg s/c every 3 hours prn

    Dose for nausea: 6.25mg - 12.5mg s/c every 3 hours prn
    07.03.05 Levonogrestrel Levonelle® 1500 Tablet Levonorgestrel 1.5mg

    To be used up to 72hours after unprotected sexual intercourse
    07.03.02.03 Levonorgestrel 13.5mg intrauterine system Jaydess® Approved by HaRD Area Precribing Committee June 2014
    07.03.02.03 Levonorgestrel 20mg intrauterine system Mirena®
    06.02.01 Levothyroxine Sodium Levothyroxine Tablets 25micrograms, 50micrograms, 100micrograms

    Liquid 25micrograms/5ml
    24.16 Lidocaine Neonatal
  • Infiltration anaesthesia: BNFc
  • 15.02 Lidocaine 2.5% with Prilocaine 2.5% Cream EMLA or Denela®
    15.02 Lidocaine HCl 2% with Chlorhexidine gluconate 0.25% gel Instillagel or Optilube Active®
    15.02 Lidocaine HCl with Adrenaline 
    02.03.02 Lidocaine Hydrochloride  Infusion 0.1%, 0.2% in glucose 5%
    02.03.02 Lidocaine Hydrochloride Minijet® Lignocaine 100mg/5ml
    15.02 Lidocaine Hydrochloride 
    15.02 Lidocaine hydrochloride LMX 4®
    12.03.01 Lidocaine Hydrochloride 2%, Chlorhexidine Gluconate Solution 0.25% Instillagel®
    15.02 Lidocaine Patch Versatis® In exceptional circumstances only - this can be used on a named patient basis by the specialist pain team - December 2017 APC
    01.06.07 Linaclotide  Constella® Approved for one patient only - September 2014
    06.01.02.03 Linagliptin Trajenta® Tablets 5mg

    For patients with CKD 3 or 4 (GFR <50ml/min)

    05.01.07 Linezolid  For use on microbiology advice ONLY
    06.02.01 Liothyronine Sodium  Injection 20micrograms
    Tablets 20micrograms

    Not supported for the treatment of hypothyroidism except for the following:
    • Patients who are allergic to levothyroxine and thus liothyronine is the only treatment option to manage their condition.
    • Post thyroidectomy thyroid cancer patients. Patients that need to receive radioactive iodine treatment after their surgery will initially be started on liothyronine due to its shorter half-life and therefore faster onset of action. These patients will be switched to levothyroxine when the course of radioactive iodine treatment is completed.
    13.02.01 Liquid and White Soft Paraffin Ointment (50:50)  500g
    01.06.03 Liquid Paraffin 
    11.08.01 Liquid Paraffin Xailin Night® Eye ointment
    06.01.02.03 Liraglutide Victoza® Pre-filled pen 18mg/3ml

    Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
    02.05.05.01 Lisinopril  Tablets 2.5mg 5mg 10mg 20mg
    04.02.03 Lithium Carbonate Priadel® MR tablets 200mg, 400mg

    Specify brand to avoid confusion between different formulations of lithium
    04.02.03 Lithium Citrate Priadel® Liquid 520mg/5ml

    Specify brand to avoid confusion between different formulations of lithium
    06.01.02.03 Lixisenatide Lyxumia® Approved by HaRD APC April 2013

    Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber).
    04.03.01 Lofepramine  Tablets 70mg
    Liquid 70mg/5ml
    04.10 Lofexidine Hydrochloride BritLofex® Tablets 200micrograms
    08.01.01 Lomustine 
    01.04.02 Loperamide Hydrochloride  Capsules 2mg; Syrup 1mg/5ml
    03.04.01 Loratadine  Formulary in Primary Care (First-line Option)

    Non-Formulary at HDFT
    04.01.02 Lorazepam  Tablets 1mg
    Injection 4mg/ml
    04.08.02 Lorazepam  Injection 4mg/ml

    An unlicensed preparation is currently in use due to a long-term manufacturing problem with the UK licensed injection.

    Restricted use
    24.01 Lorazepam 
    02.05.05.02 Losartan Potasium Cozaar® Tablets 25mg, 50mg
    03.01.05 Low range peak flow meter Mini-Wright®
    01.06.07 Lubiprostone Amitiza® Approved by the Area Prescribing Committee September 2014 in line with NICE TA318
    20 Lugols Iodine 
    24.01 Macrogol sachets 
    01.06.04 Macrogols Movicol® Paediatric Pain
    01.06.04 Macrogols Laxido®
    09.05.01.03 Magnesium Aspartate   Sachets 10mmol
    24.01 Magnesium sulfate (acute asthma) 
    09.05.01.03 Magnesium Sulphate  Injection 50% (2mmol/ml)
    Infusion 20% (Delivery Suite only)
    13.10.05 Magnesium Sulphate Paste BP 
    01.01.01 Magnesium Trisilicate Mixture BP 
    13.10.04 Malathion 0.5% Derbac-M®
    02.02.05 Mannitol  Infusion 10% 20%
    20 Measles, Mumps & Rubella Vaccine, Live MMR® Approved by the HaRD Area Prescribing Committee, March 2015 for the treatment of viral warts.
    To be recommended by a Dermatologist only
    14.04 Measles, Mumps and Rubella Vaccine, Live (MMR) 
    01.02 Mebeverine Hydrochloride  Tablets 135mg
    06.04.01.02 Medroxyprogesterone Acetate  Sayana Press®

    Medicine is licensed for self-administration - patients should be trained to self -administer by the practice nurses. Sharps bin will need prescribing.

    104 mg/0.65 ml suspension for injection.

    06.04.01.02 Medroxyprogesterone Acetate Provera® / Depo-Provera Tablets 5mg, 100mg

    Depot injection 150mg/ml

    Initiation on the advice of a specialist
    07.03.02.02 Medroxyprogesterone Acetate Depo-Provera®

    Injection 150mg/ml

    07.03.02.02 Medroxyprogesterone Acetate Sayana Press®.

    Medicine is licensed for self-administration - patients should be trained to self -administer by the practice nurses. Sharps bin will need prescribing.

    104 mg/0.65 ml suspension for injection.

    08.03.02 Medroxyprogesterone Acetate Provera®
    10.01.01 Mefenamic Acid  Tablets 500mg
    08.03.02 Megestrol Acetate Megace®
    04.01.01 Melatonin  Circadin ® MR tablets 2mg

    For initiation by Consultant Neurologists only.
    04.01.01 Melatonin   Use Circadin tablets - crush and mix with soft food.


    For initiation by Consultant Paediatrician only
    08.01.01 Melphalan Alkeran® Tablets 2mg
    04.11 Memantine Hydrochloride Ebixa®
    09.06.06 Menadiol Sodium Phosphate  Tablets 10mg

    (long-term manufacturing problem. Phytomenadione 1mg available)

    14.04 Meningococcal group C conjugate vaccine Meningitec®
    24.16 Meningococcal group C conjugate vaccine Neonatal primary immunisation schedule
    14.04 Meningococcal polysaccharide A, C, W135 and Y vaccine ACWY Vax®
    13.03 Menthol 1% in aqueous cream Menthol in aqueous cream

    100g and 500g

    Brands include Arjun and Dermacool

    03.08 Menthol and Eucalyptus Inhalation BP 1980 
    03.04.02 Mepolizumab Nucala® Injection 100mg
    For use by Respiratory consultants only
    04.07.02 Meptazinol Meptid® Tablets 200mg
    Injection 100mg/ml

    For use in obstetric analgesia only
    08.01.03 Mercaptopurine Puri-Nethol®
    01.05.03 Mercaptopurine tablets Puri-Nethol® Maintenance of remission of acute ulcerative colitis and Crohn’s disease in adults (unlicensed)
    05.01.02.02 Meropenem Meronem® Injection 1g powder

    Indicated for:
    Neutropenic Sepsis in patients with a non-severe penicillin allergy.

    Microbiology advice should be sought for all other indications.
    24.01 Meropenem  On the advice of Microbiology
    24.16 Meropenem Neonatal
    01.05.01 Mesalazine  Mezavant® XL MR tablets 1.2g
    For use by Consultant Gastroenterologists only, for patients non-compliant with other oral mesalazine preparations.
    01.05.01 Mesalazine Octasa® Tablets 400mg, 800mg - Asacol brand (for doses over 2.4g daily only);
    Foam enema 1g; Suppositories 500mg
    01.05.01 Mesalazine Pentasa® MR tablets 500mg; Retention enema 1g/100ml; Suppositories 1g
    08.01 Mesna Uromitxan®
    24.01 Metabolic formulary 
    24.16 Metanium Neonatal
    06.01.02.02 Metformin Hydrochloride Metformin® Tablets 500mg, 850mg
    Sachets 500mg
    06.01.02.02 Metformin Hydrochloride Glucophage® SR MR tablets 500mg, 750mg

    Initiation on the advice of a specialist
    04.10 Methadone Hydrochloride  Mixture 1mg/ml

    Initiation on the advice of a Consultant Psychiatrist
    08.01.03 Methotrexate  Tablets 2.5mg
    Injection 10mg, 12.5mg, 15mg, 17.5mg, 20mg, 22.5mg, 25mg, 30mg, 50mg, 75mg
    10.01.03 Methotrexate Rheumatology Tablets 2.5mg

    Injection (various strengths available in pre-filled syringes)
    13.05.03 Methotrexate 
    13.08.01 Methyl-5-Aminolevulinate Metvix®
    01.06.06 Methylnaltrexone Relistor® Injection 12mg
    For Palliative Care Consultants only
    24.01 Methylphenidate 
    04.04 Methylphenidate Hydrochloride Medikinet Tablets 10mg

    Initiation on the advice of a specialist
    10.01.02.02 Methylprednisolone Acetate Depo-Medrone® Injection 40mg/ml, 80mg/2ml, 120mg/3ml
    10.01.02.02 Methylprednisolone Acetate Depo-Medrone® with Lidocaine Injection Methylprednisolone 40mg /lidocaine 10mg/ml
    01.02 Metoclopramide  Tablets 10mg; Syrup 5mg/5ml
    See section 4.6
    17 Metoclopramide  Dose: 10mg - 20mg s/c every 6 hours prn
    24.01 Metoclopramide 
    04.06 Metoclopramide Hydrochloride  Tablets 10mg
    Liquid 5mg/5ml
    Injection 10mg/2ml
    02.02.01 Metolazone Unlicensed
    02.04 Metoprolol Tartrate  Tablets 50mg
    05.01.11 Metronidazole  Tablets 200mg, 400mg
    Liquid 200mg/5ml
    Suppositories 500mg, 1g
    24.01 Metronidazole 
  • Oral - follow BNFc
  • IV - follow prescribing and administration guide
  • 24.16 Metronidazole Neonatal
    13.10.01.02 Metronidazole 0.75% Anabact®
    12.03.02 Miconazole Daktarin® Oral gel 20mg/g
    13.10.02 Miconazole Nitrate 
    24.16 Miconazole oral gel / topical cream (Daktarin®) Neonatal
    04.08.02 Midazolam Buccolam® Buccal liquid - Pre-filled syringes (4)
    2.5mg, 5mg, 7.5mg, 10mg

    3 to 6 months(Hospital setting) 2.5mg in 0.5ml (Yellow)
    >6 months to <1 year 2.5mg in 0.5ml (Yellow)
    1 year to <5 years 5mg in 1ml (Blue)
    5 years to <10 years 7.5mg in 1.5ml (Purple)
    10 years to <18 years 10mg in 2ml (Orange)
    15.01.04.01 Midazolam 
    17 Midazolam  Dose: 2.5mg - 5mg s/c every 1 hour prn.
    24.16 Midazolam Neonatal
    24.01 Midazolam buccal (Buccolam) 
    24.01 Midazolam injection 
    02.07 Midodrine Unlicensed Tablets 5mg

    For use by specialists only
    20 MIDODRINE Tablets 2.5 mg, 5mg  For use in postural hypotension if licensed options have failed e.g. fludrocortisone
    07.01.02 Mifepristone Mifegyne® Tablets 200mg
    07.04.02 Mirabegron Betmiga® Approved by HaRD APC July 2013
    04.03.04 Mirtazapine  Tablets 15mg, 30mg
    08.01.02 Mitomycin Mitomycin C Kyowa®
    20 Mitomycin-C 
    0.2mg/1ml
    0.4mg/1ml

    Approved by HaRD Area Prescribing Committee June 2014

    For Consultant Ophthalmolgist use only
    08.01.02 Mitoxantrone (Mitozantrone) 
    15.01.05 Mivacurium Chloride Mivacron®
    04.04 Modafinil Provigil® Tablets 100mg

    Initiation on the advice of a specialist
    12.02.01 Mometasone Furoate Nasonex® Nasal spray 50micrograms/metered spray
    13.04 Mometasone Furoate 0.1% Elocon® Cream 30g, 100g
    Ointment 30g, 100g
    03.03.02 Montelukast Singulair® Tablets 10mg
    Chewable tablets 4mg, 5mg
    Granules 4mg

    For initiation by respiratory specialists only
    24.01 Montelukast 
    24.01 Morphine 
    03.09.01 Morphine Hydrochloride 
    04.07.02 Morphine Sulphate  MR tablets 10mg, 30mg, 60mg, 100mg (Zomorph preferred choice in primary care)
    Liquid 10mg/5ml, 100mg/5ml
    Injection 10mg/ml, 15mg/ml
    Syringe for PCA 50mg/50ml
    Oral solution 100micrograms/ml(for use in SCBU)
    24.16 Morphine sulphate Neonatal
    20 Morphine sulphate 100mg/100ml 
    09.05.03 Mouthwash tablets Tellodont® Soluble tablets
    12.03.04 Mouthwash tablets 
    11.03.01 Moxifloxacin 0.1mg/0.1ml (unlicensed)  Intracameral injection.
    Antibacterial prophylaxis in cataract surgery where cefuroxime is contra-indicated.
    Approved by HaRD Area Prescribing Committee Feb 2014
    02.05.02 Moxonidine  Tablets 200micrograms
    For use by a specialist only
    13.10.01.01 Mupirocin Bactroban®
    12.02.03 Mupirocin 2% in White Soft Paraffin Bactroban Nasal® Nasal ointment 2%
    09.06.07 Mutivitamin  Tablets
    08.02.01 Mycophenolate Mofetil  Prescribe generically
    02.06.04 Naftidrofuryl Oxalate  Formulary as per NICE TA223
    04.10.01 Nalmefene Selincro To be prescribed by the community alcohol service provided by North Yorkshire Horizons only.
    01.06 Naloxegol oxalate  Moventig® 12.5mg and 25mg tablets
    Approved in line with NICE TA345
    24.16 Naloxone Neonatal
    15.01.07 Naloxone Hydrochloride Naloxone®
    10.01.01 Naproxen  Tablets 250mg

    Switched to HDFT NSAID of choice November 2012 due to increased CV risk with diclofenac
    06.01.02.03 Nateglinide Starlix® Tablets 120mg

    Initiation on the advice of a specialist
    02.04 Nebivolol Nebilet® Cardiology initiation only
    11.04.02 Neodocromil Sodium Rapitil® Eye drops 2%
    10.02.01 Neostigmine  Injection 2.5mg/ml
    15.01.06 Neostigmine Metilsulfate 
    15.01.06 Neostigmine Metilsulfate with Glycopyrronium Robinul-Neostigmine®
    02.06.03 Nicorandil Ikorel® Tablets 10mg, 20mg

    For rate-control when beta-blockers and calcium channel blockers are contra-indicated.
    04.10 Nicotine Niquitin CQ® patches Patches, 7mg, 14mg and 21mg strength
    02.06.02 Nifedipine Adalat® Retard MR tablets 10mg, 20mg
    (twice daily dosing)

    Prescribe by brand
    02.06.02 Nifedipine  Capsules 5mg, 10mg
    02.06.02 Nifedipine Adalat® LA MR tablets 20mg, 30mg, 60mg
    (once daily dosing)

    Prescribe by brand
    02.06.02 Nifedipine Coracten® SR MR capsules 10mg
    (twice daily dosing)

    Prescribe by brand
    08.01.05 Nilotinib Tasigna®
    04.01.01 Nitrazepam  Tablets 5mg
    Liquid 2.5mg/ml
    05.01.13 Nitrofurantoin  Tablets 100mg
    Capsules 50mg
    Liquid 25mg/5ml
    MR capsules 100mg
    24.01 Nitrofurantoin 
    15.01.02 Nitrous oxide 
    24.01 Nitrous Oxide (Entonox) 
    24.01 Noradrenaline 
    24.16 Noradrenaline Neonatal
    02.07.02 Noradrenaline Acid Tartrate / Norepinephrine Bitartrate Noradrenaline ®/ Norepinephrine Injection 2mg/ml
    (equivalent to noradrenaline base 1mg/ml)
    06.04.01.02 Norethisterone  Tablets 5mg

    Initiation on the advice of a specialist
    08.03.02 Norethisterone 
    14.05.01 Normal Immunoglobulin for Intravenous use Privigen® There is a National Immunoglobulin Database which must be updated for every patient commenced on immunoglublin therapy.

    Sections 1-3 of the attached immunoglobulin request form must be completed by the requesting clinician and sent to Pharmacy Aseptics.
    24.16 Nutriprem 2 Neonatal
    12.03.02 Nystatin Nystan® Oral solution 100 000units/ml
    24.16 Nystatin Neonatal Oral liquid
    Topical cream discontinued
    01.09.01 Obeticholic acid  Ocaliva®
    11.08.02 Ocriplasmin 0.5 mg/0.2 ml concentrate for solution for injection Jetrea Administered by intravitreal injection only
    24.16 Octenisan Neonatal
  • Use daily as a wash from 28 weeks of age
  • 08.03.04.03 Octreotide Sandosatin® Injection 50micrograms/ml, 100micrograms/ml

    Initiation on teh advice of a specialist
    08.03.04.03 Octreotide Sandosatin Lar® Injection 10mg

    Initiation on the advice of a specialist
    06.04.01.01 Oestrogens for HRT Premique® All oestrogen and HRT products should only be prescribed on the advice of a specialist.
    Always consider lowest dose possible - refer new patients to GP for Premique low dose.
    06.04.01.01 Oestrogens for HRT Prempak-C® Tablets 1.25

    Initiation on the advice of a specialist
    06.04.01.01 Oestrogens for HRT Premarin® Tablets 625micrograms

    Initiation on the advice of a specialist
    06.04.01.01 Oestrogens for HRT Climaval® Approved by the Area Prescribing Committee, February 2015

    1mg and 2mg tablets available.
    06.04.01.01 Oestrogens for HRT Evorel® Patch 50micrograms/24 hours

    If patient experiences skin irritation from the patches, refer to GP for matrix patches
    07.02.01 Oestrogens, Topical Ortho-Gynest® Pessaries 500micrograms
    07.02.01 Oestrogens, Topical Gynest® Intravaginal cream 0.01%
    07.02.01 Oestrogens, Topical Ovestin® Intravaginal estriol cream 0.1%
    08.02.03 Ofatumumab Arzerra® Approved by the HaRD Area Prescribing Committee, March 2015
    11.03.01 Ofloxacin Exocin® Eye drops 0.3%
    04.02.01 Olanzapine Zyprexa® Tablets 2.5mg, 5mg, 10mg
    Orodispersible tablets 5mg, 10mg
    12.01.03 Olive Oil 
    03.04.02 Omalizumab Xolair® Injection 150mg

    For use by respiratory consultants only
    01.03.05 Omeprazole  Capsules 10mg 20mg
    24.01 Omeprazole 
  • Omeprazole liquid preparations are not routinely used at HDFT - use omeprazole dispersible tablets
  • 24.16 Omeprazole Neonatal
    01.03.05 Omeprazole IV 
    04.06 Ondansetron  Tablets 4mg, 8mg
    Liquid 4mg/5ml
    Injection 4mg/2ml, 8mg/4ml
    24.01 Ondansetron 
    04.09.01 Opicapone Ongentys® Approved by the Area Prescribing Committee, January 2017
    Second line treatment option for patients unable to tolerate entacapone or where it is contraindicated.
    07.03.02 Oral Progestogen-Only Contraceptives Morningside® Tablets Desogestrel 75micrograms
    07.03.02 Oral Progestogen-Only Contraceptives Micronor® Tablets Norethisterone 350micrograms
    07.03.02 Oral Progestogen-Only Contraceptives Norgeston® Tablets Levonorgestrel 30micrograms
    24.01 Oral rehydration sachets 
    09.02.01.02 Oral Rehydration Salts  Plain/Blackcurrant flavour
    04.05.01 Orlistat Xenical® Capsules 120mg

    Initiation on the advice of a specialist
    05.03.04 Oseltamivir Tamiflu® On the advice of a Microbiologist
    08.01.05 Oxaliplatin 
    04.01.02 Oxazepam  Tablets 10mg, 15mg

    For alcohol detoxification if impaired liver function
    11.07 Oxybuprocaine Hydrochloride Minims® Eye drops 0.4%
    07.04.02 Oxybutynin Hydrochloride  Tablets 2.5mg, 5mg
    Liquid 2.5mg/5ml
    17 Oxycodone  Opiate of choice in moderate renal function
    04.07.02 Oxycodone Hydrochloride OxyContin® MR tablets 5mg, 10mg, 40mg, 80mg

    For regular TWICE DAILY dosing

    Morphine is first line strong opioid of choice
    04.07.02 Oxycodone Hydrochloride OxyNorm® Standard release capsules 5mg, 10mg
    (PRN for breakthrough pain)

    Liquid 5mg/5ml (250ml bottles)
    Liquid 50mg/5ml (120ml bottles)

    Injection 10mg/ml, 20mg/2ml, 50mg/ml
    05.01.03 Oxytetracycline  Tablets 250mg
    07.01.01 Oxytocin Syntocinon® Injection 5units/ml, 10units/ml
    08.01.05 Paclitaxel 
    04.02.02 Paliperidone Xeplion 50mg, 75mg, 100mg, 150mg prefilled syringe
    24.16 Palivizumab Neonatal
  • Restricted to use for RSV prophylaxis in patients who meet the Yorkshire and Humber Specialised Commissioning Group criteria
  • 04.06 Palonosetron with netupitant Akynzeo® Approved by HaRD APC April 2017
    01.09.04 Pancreatin Creon® 10000
    01.09.04 Pancreatin Creon® 40000
    01.09.04 Pancreatin Creon® 25000
    24.16 Pancuronium Neonatal
    15.01.05 Pancuronium Bromide 
    14.04 Pandemic Influenza A(H1N1)v vaccine Celvapan®
    08.01.05 Panitumumab ®
    04.07.01 Paracetamol  Tablets 500mg, Soluble tablets 500mg
    Suppositories 60mg, 120mg, 250mg, 500mg
    Liquid 120mg/5ml, 250mg/5ml

    Intravenous infusion 10mg/ml*
    * Restricted
    04.08.03 Paracetamol  For formulations see under Analgesics
    24.01 Paracetamol 
    24.16 Paracetamol Neonatal
    04.07.01 Paracetamol and codeine Co-codamol® 30/500 Tablets
    04.07.01 Paracetamol and codeine Co-codamol® 8/500 Tablets
    Soluble tablets
    04.07.01 Paracetamol and dihydrocodeine Co-dydramol® Tablets 10/500
    20 PARAFFIN WHITE SOFT BP 350g 
    24.01 Paraldehyde & oilve oil enema  Unlicensed
    20 PARALDEHYDE 50% in olive oil enema 30ml 
    15.01.04.02 Parecoxib Dynastat®
    07.03.02.02 Parenteral Progestogen Only Contraceptives Nexplanon® Implant Etonorgestrel 68mg
    04.03.03 Paroxetine  Tablets 20mg, 30mg
    Liquid 10mg/5ml
    20 PATENT BLUE Injection 2.5% 
    09.01.06 Pegfilgrastim Neulasta® Pre-filled syringe 6mg/0.6ml

    Initiation by Consultant Haematologist/Oncologist only
    08.01.03 Pemetrexed Alimta®
    20 PENTOSAN POLYSULPHATE 100mg capsules Elmiron® Request through HaRD APC on an individual named patient basis
    02.06.04 Pentoxifylline Trental®
    01.02 Peppermint Oil Mintec® Capsules e/c 0.2ml
    01.02 Peppermint water 
    20 PEPPERMINT WATER BP 
    01.01.02 Peptac 
    04.08.01 Perampanel Fycompa® Initiation on the advice of a Specialist
    02.05.05.01 Perindopril erbutine  Tablets 2mg 4mg
    For use by specialists in stroke patients only
    Perindopril Erbutine only
    13.10.04 Permethrin 
    04.07.02 Pethidine Hydrochloride  Injection 50micrograms/ml, 100micrograms/2ml
    04.08.01 Phenobarbital  Tablets 30mg
    Liquid 50mg/5ml (alcohol free)
    Injection 30mg/ml, 200mg/ml
    24.01 Phenobarbital (Phenobarbitone) 
    24.16 Phenobarbital (Phenobarbitone) Neonatal
    05.01.01.01 Phenoxymethylpenicillin  Tablets 250mg
    Syrup 125mg/5ml & 250mg/5ml
    24.01 Phenoxymethylpenicillin 
    24.16 Phenylephrine 2.5% minims Neonatal
    11.05 Phenylephrine Hydrochloride Minims® Phenylephrine Hydrochloride Eye drops 2.5%, 10%
    04.08.01 Phenytoin  Phenytoin sodium
    Tablets 100mg, Chewable tablets 50mg
    Capsules 25mg, 50mg, 100mg
    Injection 250mg/5ml

    Phenytoin
    Liquid 30mg/5ml

    (Phenytoin sodium 100mg = Phenytoin 90mg)
    24.01 Phenytoin 
    24.16 Phenytoin Neonatal
    03.09.01 Pholcodine Linctus, BP  Liquid 5mg/5ml
    09.05.02.01 Phosphate supplements  Effervescent tablets (Phosphate Sandoz):
    Phosphate 16.1mmol, Potassium 3.1mmol, Sodium 20.4mmol per tablet

    Polyfusor (500ml):
    Phosphate 50mmol, Potassium 9.5mmol, Sodium 81mmol in 500ml
    01.06.04 Phosphates (Rectal) Fleet® Ready to use Enema
    09.06.06 Phytomenadione Konakion® MM Injection 10mg/ml
    09.06.06 Phytomenadione Konakion® MM Paediatric Injection (can be used orally) 2mg/0.2ml
    11.06 Pilocarpine  Eye drops 1%, 2%, 4%
    Minims 4%
    13.05.03 Pimecrolimus Elidel®
    06.01.02.03 Pioglitazone Actos® Tablets 30mg

    Initiation on the advice of a specialist
    05.01.01.04 Piperacillin and Tazobactam  Injection 4.5g powder

    Should be prescribed as 'piperacillin/tazobactam' to identify it as a penicillin.

    Approved Indications:
    Hospital Acquired Pneumonia (HAP)
    Ventilator Associated Pneumonia (VAP)
    Aspiration Pneumonia
    Neutropenic Sepsis

    Microbiology advice should be sought for all other indications

    05.01.01.05 Pivmecillinam Selexid® Tablets 200mg
    04.07.04.02 Pizotifen  Tablets 500micrograms
    14.04 Pneumococcal polysaccharide conjugate vaccine (13-valent adsorbed) Prevenar 13®
    14.04 Pneumococcal polysaccharide vaccine Pneumovax® II
    24.16 Pneumococcal vaccine (Prevenar13) Neonatal
    13.07 Podophyllotoxin Warticon®
    06.01.06 Polycal 
    09.02.01.01 Polystyrene Sukphonate Resins Calcium Resonium® Oral powder
    11.08.01 Polyvinyl Alchohol SnoTears® Eye drops 1.4%
    11.08.01 Polyvinyl Alcohol Liquifilm Tears® Single dose eye drops 1.4%
    08.02.04 Pomalidomide Imnovid®
    24.16 Poractant alfa (Curosurf) Neonatal
    09.02.01.01 Potasium Chloride Sando-K® Effervescent tablets (12mmol potassium)
    09.02.01.01 Potasium Chloride Slow-K® MR tablets 600mg (8mmol potassium)
    09.02.01.01 Potasium Chloride Kay-Cee-L® Liquid 1mmol/ml potassium
    09.02.02.01 Potassium Chloride and Glucose Intravenous Infusion   Potassium 0.15%(20mmol), Glucose 5% (1000ml)
    Potassium 0.3%(40mmol), Glucose 5% (1000ml)
    Potassium 0.3%(40mmol), Glucose 10% (500ml)
    09.02.02.01 Potassium Chloride and Sodium Chloride Intravenous Infusion  Potassium 0.15%(20mmol), NaCl 0.9% (1000ml)
    Potassium 0.3%(40mmol), NaCl 0.9% (1000ml)
    Potassium 0.45%(60mmol), NaCl 0.9% (1000ml)
    *Potassium 0.6%(80mmol), NaCl 0.9% (500ml)*

    *ECG monitoring required
    09.02.02.01 Potassium Chloride Concentrate (Sterile)  Pre-filled syringe 50mmol/50ml

    For use on ITU only
    09.02.02.01 Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion  Potassium 0.15%(20mmol),NaCl 0.45%,Glucose 5% (500ml)

    Potassium 0.3%(40mmol),NaCl 0.18%,Glucose 4% (1000ml)

    Potassium 0.3%(40mmol),NaCl 0.45%,Glucose 5% (500ml)

    *Potassium 0.15%(20mmol),NaCl 0.18%,Glucose 4% (500ml)

    *SCBU only
    07.04.03 Potassium Citrate  Mixture 200ml
    13.11.06 Potassium Permanganate Permitabs®
    13.11.04 Povidone-Iodine Videne®
    04.09.01 Pramipexole  Tablets 180micogram base (= 250micogram salt),
    700micogram base (= 1000microgram salt)

    Initiation on the advice of a specialist


    MR formulation: Individual patient request required through LPG. Preferred product of choice in primary care is Pipexus MR
    02.09 Prasugrel Efient® Tablets 5mg, 10mg

    For use by a specialist only
    02.12 Pravastatin Sodium  Tablets 10mg, 20mg

    Use if adverse effects with simvastatin
    01.05.02 Prednisolone Predfoam® Foam enema 20mg
    01.05.02 Prednisolone Predsol Retention enema 20mg/100ml
    01.05.02 Prednisolone Predsol Retention enema 20mg/100ml; Suppositories 5mg
    06.03.02 Prednisolone  Tablets 1mg, 5mg
    11.04.01 Prednisolone  Eye drops 0.5%
    Eye drops 1% (Predforte)
    11.04.01 Prednisolone Minims® Prednisolone Sodium Phosphate Eye drops 0.5%
    24.01 Prednisolone 
    04.07.03 Pregabalin  Also approved as an unlicensed indication pre-operatively as part of the gynae enhanced recovery protocol.
    04.08.01 Pregabalin 
    15.02 Prilocaine 2% injection Prilotekal® Approved by HaRD Area Prescribing Committee September 2013:
    For subarachnoid block in adult day surgery cases where procedures last under 1 hour
    15.02 Prilocaine Hydrochloride Citanest®
    15.02 Prilocaine Hydrochloride with Felypressin Citanest with Octapressin®
    03.05.02 Proactant Alfa Curosurf® Injection 120mg, 240mg

    For use on Special Care Baby Unit only
    20.01 Probiotics VSL #3 Sachets and other brands •Only approved for adults (pouchitis)

    •All other indications: BLACK - Not recommended for prescribing within the Harrogate and Rural District CCG.
    04.06 Prochlorperazine  Tablets 5mg
    Liquid 5mg/5ml
    Injection 12.5mg/ml
    04.06 Prochlorperazine Buccastem® (Buccal preparation)
    04.09.02 Procyclidine Hydrochloride  Tablets 5mg
    Liquid 5mg/5ml
    Injection 10mg/2ml
    04.06 Promethazine Hydrochloride  Tablets 25mg
    Liquid 5mg/5ml
    Injection 25mg/ml
    15.01.01 Propofol 
    24.01 Propranolol 
    24.01 Propranolol (haemangioma)  Unlicensed indication
    02.04 Propranolol Hydrochloride 
    02.04 Propranolol Hydrochloride Inderal® LA MR Capsules 160mg
    02.04 Propranolol Hydrochloride Half-Inderal® LA MR Capsules 80mg
    16.01 ProSource Plus  Approved by the HaRD Area Prescribing Committee, March 2015
    02.08.03 Protamine Sulphate  Injection 10mg/ml
    24.16 Proxymetacaine 0.5% eye drops Neonatal
    11.07 Proxymetacaine Hydrochloride 0.5% with Fluorescein Sodium 0.25% Minims®
    01.06.07 Prucalopride Resolor

    Tablets 1mg

    Initiation on the advice of a specialist only.
    For chronic constipation in adults when all other laxatives have been ineffective after 6 months.

    03.10 Psudoephedrine Hydrochloride Gulpseud®
    03.10 Psudoephedrine Hydrochloride Sudafed® Tablets 60mg
    Liquid 30mg/5ml
    05.01.09 Pyrazinamide 
    10.02.01 Pyridostigmine Bromide Mestinon® Tablets 60mg
    09.06.02 Pyridoxine Hydrochloride Pyridoxine Tablets 50mg
    04.02.01 Quetiapine Seroquel® Tablets 25mg, 100mg, 200mg, 300mg
    06.07.01 Quinagolide Norprolac® Tablets 25 & 50micrograms (in starter pack), Tablets 75micrograms

    Initiation on the advice of a specialist
    10.02.02 Quinine sulphate  Tablets 200mg
    06.04.01.01 Raloxifene Hydrochloride Evisa®
    02.05.05.01 Ramipril  Capsules 2.5mg 5mg 10mg
    11.08.02 Ranibizumab Lucentis® Intravitreal injection 10mg/ml

    Initiation by Consultant Ophthalmologist only
    01.03.01 Ranitidine  Tablets 150mg, 300mg; Liquid 75mg/5ml
    24.01 Ranitidine 

    APC April 2018 -Effervescent ranitidine tablets should be used in patients under 6 years old instead of liquid due to the alcohol content of the liquid being contraindicated for this group.

    24.16 Ranitidine Neonatal

    APC April 2018- Effervescent ranitidine tablets should be used in patients under 6 years old instead of liquid due to the alcohol content of the liquid being contraindicated for this group.

    01.03.01 Ranitidine IV  Injection 50mg/2ml
    02.06.03 Ranolazine Ranexa® MR tablets 375mg, 500mg

    For use by Cardiologists only as last line therapy for unstable angina
    04.09.01 Rasagiline Azilect® Tablets 1mg

    Initiation on the advice of a specialist
    04.03.04 Reboxetine Edronex® Tablets 4mg
    15.01.04.03 Remifentanil Ultiva®
    03.04.02 Reslizumab  Cinqaero For use by Respiratory Consultants Only
    For severe eosinophilic asthma
    04.08.01 Retigabine Trobolt® Tablets 50mg, 100mg

    Initiation on the advice of a specialist only.
    Used as add on treatment in patients with focal onset seizures, which have not been controlled with all other licensed anti-epileptic drug.
    Comprehensive eye examination required prior to initiation and then repeated every 6 months.
    05.01.09 Rifampicin  Capsules 150mg, 300mg
    Liquid 100mg/5ml
    Infusion 600mg
    05.01.09 Rifampicin and Isoniazid Rifinah® 150 and 300
    05.01.09 Rifampicin and Isoniazid and Pyrazinamide Rifater®
    05.01.07 Rifaximin 550mg tablets Targaxan® Approved by the Area Prescribing Committee, May 2015, in line with NICE TA337
    04.09.03 Riluzole Rilutek® Tablets 50mg

    Initiation on the advice of a specialist
    11.04.01 Rimexolone Vexol® Eye drops 1%
    04.05.02 Rimonabant Acomplia® Not stocked at HDFT

    Initiation on the advice of a specialist
    06.06.02 Risedronate Sodium Actonel® Tablets 35mg

    Tablets 30mg (for Pagets disease only)

    04.02.01 Risperidone Risperdal® Tablets 500 micrograms, 1mg, 3mg
    Liquid 1mg/ml
    04.02.02 Risperidone Risperdal Consta® Injection 25mg, 37.5mg, 50mg
    07.01.03 Ritodrine Hydrochloride Yutopar® Tablets 10mg
    08.02.03 Rituximab Truxima®
    10.01.03 Rituximab Truxima® Initiation on the advice of a specialist
    02.08.02 Rivaroxaban Xarelto® As per NICE guidelines
    04.11 Rivastigmine  Capsules 1.5mg
    Patches 4.6mg

    Initiation on the advice of a specialist.

    Patches ONLY for patients unable to take capsules.
    20 ROBINUL-NEOSTIGMINE inj (1ml) 
    15.01.05 Rocuronium Bromide Esmeron®
    03.03.03 Roflumilast Daxas 500mcg tablets

    Not currently prescribed at HDH
    04.09.01 Ropinirole  Tablets 250micrograms, 1mg

    Initiation on the advice of a specialist
    04.09.01 Ropinirole MR (XL)  Ipnnia XL® 2mg, 3mg, 4mg, 6mg and 8mg tablets
    02.12 Rosuvastatin Crestor® Tablets 5mg, 10mg, 20mg

    For use by Consultant Cardiologists only
    14.04 Rotavirus vaccine Rotarix®
    24.16 Rotavirus vaccine (Rotarix) Neonatal
    04.09.01 Rotigotine Neupro® Patches 2mg, 4mg, 6mg, 8mg

    Initiation on the advice of a specialist
    02.05.05.02 Sacubitril/valsartan  Entresto® To be prescribed in line with NICE TA388
    04.09.01 Safinamide Xadago® 50mg and 100mg film coated tablets
    Approved by the HaRD Area Prescribing Committee December 2016
    03.01.01.01 Salbutamol  Inhaler 100micrograms/dose
    Easyhaler 100micrograms/dose
    Nebules 2.5mg/2.5ml, 5mg/2.5ml
    MR tablets 4mg
    Liquid 2mg/5ml
    Injection 500micrograms/ml (hospital only)
    07.01.03 Salbutamol  Nebules 5mg
    24.01 Salbutamol 
    24.16 Salbutamol Neonatal
  • For the management of hyperkalaemia. If IV route is unavailable, follow guidance in BNFc.
  • 13.07 Salicylic Acid Occlusal®
    13.05.02 Salicylic Acid 2% w/w, Sulphur 2% w/w in Aqueous Cream 
    13.06.01 Salicylic Acid 3% w/w, Sulphur 3% w/w in Aqueous Cream 
    13.05.02 Salicylic Acid in White Soft Paraffin 
    13.06.01 Salicylic Acid in White Soft Paraffin 
    03.01.01.01 Salmeterol Serevent®
    10.01.03 Sarilumab  
    01.07.02 Scheriproct  Ointment
    20.01 Secukinumab  Cosentyx® Approved in line with NICE TA350
    04.09.01 Selegiline Hydrochloride  Tablets 5mg
    Liquid 10mg/5ml
    01.06.02 Senna  Tablets 7.5mg; Liquid 7.5mg/5ml
    04.03.03 Sertraline  Tablets 50mg, 100mg
    09.05.02.02 Sevelamer Renagel® Tablets 800mg

    Initiation on the advice of a Renal Specialist
    15.01.02 Sevoflurane 
    13.09 Shampoos Capasal®
    04.05.02 Sibutramine Hydrochloride Reductil® Capsules 10mg

    Initiation on the advice of a specialist
    07.04.05 Sildenafil Viagra®
    13.07 Silver Nitrate 
    13.10.01.01 Silver Sulfadiazine Flamazine®
    03.09.02 Simple Linctus, BP 
    02.12 Simvastatin  Tablets 20mg, 40mg
    08.02.02 Sirolimus Rapamune®
    06.01.02.03 Sitagliptin Januvia® Tablets 100mg

    Initiation on the advice of a specialist
    24.01 Sodium benzoate  Unlicensed
    09.02.01.03 Sodium Bicarbonate  Capsules 500mg
    09.02.02.01 Sodium Bicarbonate Min-I-Jet® Sodium Bicarbonate Minijet 4.2%, 8.4%
    12.01.03 Sodium Bicarbonate  Ear drops 5%
    24.16 Sodium bicarbonate Neonatal
    09.02.02.01 Sodium Bicarbonate Infusion  Polyfusor
    1.26% (500ml)
    2.74% (500ml)
    4.2% (500ml)
    8.4% (200ml)
    03.01.05 Sodium Chloride  Sodium chloride 0.9% 5ml, 10ml

    24.16 Sodium chloride Neonatal
  • Oral product used at HDFT is sodium chloride 1mmol/1mL 200mL (unlicensed medicine)
  • 13.11.01 Sodium Chloride 0.9% 
    09.02.02.01 Sodium chloride 3% solution Hypertonic saline
    09.02.02.01 Sodium Chloride and Glucose Intravenous Infusion  NaCl 0.9%, Glucose 5% (500ml)
    NaCl 0.45%, Glucose 5% (500ml)
    NaCl 0.18%, Glucose 4% (500ml)
    NaCl 0.18%, Glucose 4% (1000ml)
    NaCl 0.18%, Glucose 10% (500ml)
    09.02.02.01 Sodium Chloride Intravenous  0.45% (500ml)
    0.9% (50ml & 50ml Minibag plus)
    0.9% (100ml & 100ml Minibag plus)
    0.9% (250ml)
    0.9% (500ml)
    0.9% (1000ml)
    5% Polyfusor (500ml)
    07.04.04 Sodium Citrate  Solution for bladder irrigation 30ml
    01.06.04 Sodium Citrate (Rectal) Micralax® Micr-enema
    11.04.02 Sodium Cromoglicate  Eye drops 2%
    09.01.01.01 Sodium Feredetate Sytron® Liquid 27.5mg iron in 5ml
    05.01.07 Sodium fusidate  Tablets 250mg
    Liquid 250mg/5ml (Dose of 750mg TDS equivalent to 500mg TDS for tablets)
    Infusion 500mg powder with diluent
    11.08.01 Sodium hyaluronate 0.2% Xailin HA® Approved by the Area Prescribing Committee, August 2016
    13.11.04 Sodium Hypochorite Solution 1% Milton®
    09.02.02.01 Sodium Lactate Intravenous Infusion, Compound  500ml, 1000ml
    24.16 Sodium Phosphate Neonatal Joulies phosphate solution (unlicensed medicine)
    01.06.02 Sodium Picosulfate  Elixir 5mg/5ml
    24.01 Sodium picosulfate 
    04.08.01 Sodium Valproate  Crushable tablets 100mg
    EC tablets 200mg, 500mg
    MR tablets 300mg, 500mg
    Liquid 200mg/5ml
    Injection 300mg/3ml
    24.01 Sodium valproate 
    07.04.02 Solifenacin Succinate Vesicare® Tablets 5mg, 10mg

    02.04 Sotalol Hydrochloride  Tablets 40mg, 80mg
    02.02.03 Spironolactone 
    24.16 Spironolactone Neonatal
    03.01.05 Standard range peak flow meter MicroPeak®
    13.11.07 Sterile Larvae (Maggots) LarvE®
    12.03.03 Strepsils lozenges  Original
    02.10.02 Streptokinase  Injection 1.5million units

    Intrapleural use for empyema
    06.06.02 Strontium Ranelate Protelos® Granules 2g

    3rd line option if alendronate and risedronate not tolerated.

    Avoid in immobile patients or history of venous thromboembolism.
    01.03.03 Sucralfate Antepsin® Unlicensed preparation approved for use by the gastroenterology consultants only.

    Approved as a Red Drug until the licensed preparation is available again.
    20 Sucralfate 2g/50ml enema  Management of chronic radiation proctitis.
    20 Sucrose 24% Sweet-Ease® For procedural pain relief in neonates
    01.05.01 Sulfasalazine  Tablets plain/ e/c 500mg (note plain tablets are cheaper than e/c in primary care)
    10.01.03 Sulfasalazine  Tablets EC 500mg
    04.02.01 Sulpiride  Tablets 200mg; Liquid 200mg/5ml
    04.07.04.01 Sumatriptan  Tablets 50mg
    24.01 Sumatriptan 
    24.16 Suxamethonium Neonatal
    15.01.05 Suxamethonium Chloride 
    24.16 Syrup BP Neonatal Unlicensed
    For cannulation
    24.16 Sytron (Sodium feredetate) Neonatal For all breast milk fed babies, particularly if:
    1. Weight <1500g
    2. <34 weeks gestation
    3. IUGR

    Consider iron supplementation in mixed fed infants if they are fed more breast milk than formula.

    Commence at 28 days of age.
    Continue up to 6-12 months of age depending on diet.

    Dose: 1ml per day or 0.5ml per day if mixed fed.

    Note: ESPGHAN recommends a dose of 2-3mg/kg/day. Iron supplementation may be started at 2-6 weeks of postnatal age. Anaemia of prematurity is not iron deficiency.
    08.02.02 Tacrolimus Advagraf® Capsules 500micrograms, 1mg

    Prescribe by brand

    For use by Renal Unit only
    08.02.02 Tacrolimus Prograf® Capsules 500micrograms, 1mg

    Prescribe by brand due to interpatient variability
    08.02.02 Tacrolimus Adoport® Prescribe by brand
    13.05.03 Tacrolimus Protopic®
    20 TALC BP purified sterile 4g,10g 
    08.03.04.01 Tamoxifen  Tablets 10mg, 20mg
    07.04.01 Tamsulosin Hydrochloride  Capsules 400micrograms
    13.05.02 Tars Coal Tar Paster BP
    13.05.02 Tars Cocois®
    13.05.02 Tazarotene 0.05% Zorac®
    05.01.07 Teicoplanin Targocid® Injection 200mg & 400mg powder
    04.01.01 Temazepam  Tablets 10mg, 20mg
    Liquid 10mg/5ml
    05.01.01.02 Temocillin Negaban® Microbiology advice only
    02.10.02 Tenecteplase Metalyse® Injection 8000units, 10000units

    Use in accordance with thrombolysis protocol.
    13.10.02 Terbinafine Hydrochloride 1% Lamisil®
    03.01.01.01 Terbutaline Sulphate Bricanyl® Turbohaler 500micrograms/dose
    Liquid 1.5mg/5ml
    07.01.03 Terbutaline Sulphate  Injection 500micrograms/ml
    06.06.01 Teriparatide Forsteo®

    Pre-filled pen 250 micrograms/ml

    For use by Consultant Rheumatologists and Dr Hammond only

    06.05.02 Terlipressin Variquel® Injection 1mg
    06.01.06 Test Strips Multistix 8SG®
    06.01.06 Test strips Contour  
    06.01.06 Test Strips Freestyle optium  
    06.01.06 Test strips Freestyle optium beta-ketone 
    06.01.06 Test strips Gluco Rx HCT  
    06.01.06 Test strips Gluco Rx Ketone  
    06.01.06 Test strips GlucoMen LX sensor 
    06.01.06 Test strips GlucoRx Nexus test strips 
    06.01.06 Test Strips: GluNeo test strips 
    06.04.02 Testosterone and Esters Sustanon 250® Injection 1ml (oily) - Testosterone propionate 30mg, testosterone phenylpropionate 60mg, testosterone isocaproate 60mg, testosterone decanoate

    Initiation on the advice of a specialist
    06.04.02 Testosterone and Esters Testosterone (implant) Implant 200mg

    Initiation on the advice of a specialist
    06.04.02 Testosterone and Esters Testogel® Gel sachets 50mg

    Initiation on the advice of a specialist
    14.05.02 Tetanus immunoglobulin 
    15.02 Tetracaine (Amethocaine) Ametop®
    24.16 Tetracaine (Ametop®) Neonatal
    11.07 Tetracaine Hydrochloride Minims® Amethocaine Hydrochloride Eye drops 1%
    06.05.01 Tetracosactide Synacthen® Injection 250micrograms/ml
    24.01 Tetracosactide (Synacthen) 
    09.02.02.02 Tetrastarch Volulyte® 6% (500ml)
    08.02.04 Thalidomide Pharmion® Capsules 50mg

    Patient authorisation form must be sent with each prescription
    03.01.03 Theophylline  See under individual brand names

    Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
    03.01.03 Theophylline Nuelin® SA MR tablets 175mg, 250mg

    Prescribe by brand.

    Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
    03.01.03 Theophylline Slo-Phyllin® MR capsules 60mg, 125mg

    Prescribe by brand.

    Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
    03.01.03 Theophylline Uniphyllin® Continus MR tablets 200mg, 300mg, 400mg

    Prescribe by brand.

    Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin.
    09.06.02 Thiamine  Tablets 50mg, 100mg
    09.06.02 Thiamine Pabrinex® IM injection
    IV injection
    24.16 Thick and Easy Neonatal
    15.01.01 Thiopental Sodium 
    04.08.01 Tiagabine Gabitril® Not stocked at HDFT

    Initiation on the advice of a Neurologist
    12.02.01 Tiamcinolone Acetonide Nasacort® Aqueous nasal spray 55micrograms/metered spray
    02.09 Ticagrelor Brilique® 60mg tablets
    90mg tablets
    05.01.03 Tigecycline Tygacil® Injection 50mg powder

    For use on microbiology advice ONLY
    24.01 Timolol 0.5% long acting eye drops (topical treatment of haemangioma)  Unlicensed indication of a licensed drug
    11.06 Timolol Maleate  Eye drops 0.25%, 0.5%
    11.06 Timolol Maleate Once-daily Timoptol®-LA Infantile haemangioma
    24.01 Tinzaparin 
    02.08.01 Tinzaparin Sodium 
    03.01.02 Tiotropium Spiriva® Respimat® 2.5mcg/dose
    Handihaler® 18mcg/dose
    03.01.04 Tiotropium / olodaterol Respimat  Spiolto Respimat Licnensed for COPD only
    02.09 Tirofiban Aggrastat®
    10.02.02 Tizanidine  Tablets 2mg

    Initiation on the advice of a specialist
    05.01.04 Tobramycin (Bramitob) 75mg/ml Nebuliser solution
    05.01.04 Tobramycin Podhaler Tobi®
    10.01.03 Tocilizumab RoActemra®
    10.01.03 Tocilizumab RoActemra®

    Approved by the HaRD Area Prescribing Committee, January 2015

    10.01.03 Tofacitinib Xeljanz For initiation by Consultant Rheumatologists
    07.04.02 Tolterodine Tartrate Detrusitol® Tablets 1mg (twice daily dosing)
    07.04.02 Tolterodine Tartrate modified release Detrusitol® XL MR Capsules 4mg (once daily dose)

    06.05.02 Tolvaptan Samsca® Patients requiring tolvaptan are managed by York Teaching Hospitals
    04.08.01 Topiramate Topamax®
    24.01 Topiramate (migraine) 
    04.07.02 Tramadol Hydrochloride  Capsules 50mg
    Injection 100mg/2ml
    MR tablets - restricted to patients non-compliant with regular tramadol
    02.11 Tranexamic Acid  Tablets 500mg; Injection 500mg/5ml
    24.01 Tranexamic acid 
    08.01.05 Trastuzumab Herceptin®
    08.01.05 Trastuzumab emtansine Kadcyla® Approved in February 2014 as per Cancer Drugs Fund (CDF)guidelines
    11.06 Travoprost Travatan® For when patients have poor response to latanoprost
    11.06 Travoprost with Timolol DuoTrav®
    04.03.01 Trazodone Hydrochloride  Capsules 50mg, 100mg
    Liquid 50mg/5ml
    08.01.05 Tretinoin  One box stored in Pharmacy EMCU.
    Out of Hours; please contact the on-call pharmacist
    10.01.02.02 Triamcinolone Acetonide Kenalog®
    20 TRICHLORACETIC ACID 90% SOLUTION  Approved by HaRD Area Prescribing Committee January 2014 for Consultant Dermatologists use only.
    13.11.05 Triclosan 2% Aquasept®
    04.02.01 Trifluoperazine  Tablets 1mg, 5mg
    Liquid 5mg/5ml
    08.01.05 Trifluridine / Tipiracil  Lonsurf® NICE TA405: Trifluridine–tipiracil for previously
    treated metastatic colorectal cancer
    04.09.02 Trihexyphenidyl Hydrochloride  Tablets 2mg, 5mg
    Liquid 5mg/5ml

    (previously known as benzhexol)
    02.06 Trimetazidine Unlicensed MR Tablets 35mg

    For use by specialists as last line therapy for unstable angina
    05.01.13 Trimethoprim  Tablets 100mg, 200mg
    Liquid 50mg/5ml
    24.01 Trimethoprim 
    24.16 Trimethoprim Neonatal
    08.03.04.02 Triptorelin Gonapeptyl Depot® Injection 3.75mg

    Paediatric use only for precocious puberty
    11.05 Tropicamide Mydriacyl® Eye drops 0.5%
    11.05 Tropicamide single use Minims® Tropicamide Eye drops 0.5%, 1%
    07.04.02 Trospium Chloride Regurin® XL
    20 TUBERCULIN PPD 2TU Injection 20 units in 1 mL 
    24.01 Tuberculosis medicines 
    06.04.01.02 Ulipristal acetate Esmya®

    February 2018 Area Prescribing Committee - No new treatment courses to be prescribed following MHRA advice.

    Originally approved by the Area Prescribing Committee September 2012.

    07.03.05 Ulipristal Acetate EllaOne® Tablet Ulipristal acetate 30mg

    To be used 72-120hourse after unprotected sexual intercourse
    03.01.02 Umeclidinium Incruse® Ellipta Licensed for COPD only.
    03.01.04 Umeclidinium / vilanterol Anoro Ellipta® Licensed for COPD only
    02.08.01 Unfractionated Heparin  Sub-cutaneous injection 5000 units/0.2ml - for VTE prophylaxis if CrCl <10ml/min.

    Injection 1000units/ml (20ml ampoules) - for use as an infusion (see individual charts).

    Injection 50 units/5ml - For central lines and paediatric peripheral lines only.

    Heparinised saline 1000 units/500ml
    For use in cardiac unit only.
    01.07.02 Uniroid HC  For Primary Care prescribing only; product not stocked at HDH
    13.02.01 Urea 40% Special Preparation  50g

    Not kept as stock in pharmacy
    07.04.04 Urinary Catheter Balloon containing Triclosan Farcofill® For patients who require catheter changes more than once every 4 weeks or who require maintenance solutions more than once every 2 weeks.
    This was approved by the APC for 4 patients per District Nursing Team (North, South, East and West).
    02.10.02 Urokinase Syner-KINASE® Injection 25000 units

    For thrombosed intravascular catheters and cannulae & peripheral vascular occlusion
    24.01 Urokinase 
    01.09.01 Ursodeoxycholic acid Ursogal® Tablets 150mg
    01.09.01 Ursodeoxycholic acid Ursofalk® Capsules 250mg; Suspension 250mg/5ml
    13.05.03 Ustekinumab Stelara®
    24.16 Vaccines - primary immunisation course Neonatal
    05.03.02.02 Valganciclovir Valcyte®
    04.02.03 Valproic Acid Depakote® Tablets 250mg
    02.05.05 Valsartan Diovan® Tablets 40mg; Capsules 80mg, 160mg

    For heart failure post myocardial infarction only
    24.01 Vamcomycin 
    05.01.07 Vancomycin  Injection 500mg & 1g powder (hospital only)
    Capsules 125mg
    24.16 Vancomycin Neonatal
    04.10 Varenicline Champix® Tablets 500micrograms, 1mg

    14.05.02 Varicella-Zoster immunoglobulin 
    06.05.02 Vasopressin Pitressin® Injection 20units/ml
    01.05.03 Vedolizumab Entyvio® Approved in line with NICE TA342 and NICE TA352
    04.03.04 Venlafaxine Efexor® Tablets 37.5mg, 75mg

    (Twice daily dosing)

    Doses above 300mg on the advice of a specialist (AMBER-shared care)
    04.03.04 Venlafaxine Efexor® XL Capsules 75mg, 150mg

    To be initiated only in patients non-compliant with twice daily dosing.

    Doses above 300mg on the advice of a specialist
    02.06.02 Verapamil Hydrochloride  Tablets 40mg, 80mg, 120mg;
    Injection 5mg/2ml (hospital only)
    11.08.02 Verteporfin Visudyne® Injection 15mg
    04.08.01 Vigabatrin Sabril® Tablets 500mg
    Sachets 500mg

    Initiation on the advice of a Neurologist
    08.01.04 Vinblastine Sulphate 
    08.01.04 Vincristine Sulphate 
    08.01.04 Vinorelbine 
    09.06.02 Vitamin B complex preparations Vigranon B® Long-term manufacturing problem
    09.06.02 Vitamin B Tablets (Compound Strong)  Contain nicotinamide 20mg, pyridoxine 2mg, riboflavin 2mg, thiamine 5mg
    20 Vitamin D - Colecalciferol 25micrograms (1000units)  Licensed as a dietary supplement
    24.16 Vitamin K (phytomenadione) Neonatal
    10.03.02 Voltarol Emulgel® 
    05.02.01 Voriconazole  On the advice of a specialist
    24.01 Warfarin 
    02.08.02 Warfarin Sodium 
    09.02.02.01 Water for Injection  5ml, 10ml, 20ml, 100ml
    13.02.01 White Soft Paraffin BP  500g
    02.02.01 Xipamide Diurexan®
    12.02.02 Xylometazoline Hydrochloride Otrivine® Nasal drops 0.1%

    Paediatric nasal drops 0.05%
    13.02.01 Yellow Soft Parrafin BP  15g
    13.02.01 Zeroveen®  Not stocked at HDH
    24.16 Zidovudine Neonatal
  • Follow BHIVA guidelines
  • 20 ZINC & SALICYLIC ACID PASTE BP (lassars paste) 60g 
    13.02.02 Zinc and Caster Oil Ointment BP  15g
    09.05.04 Zinc Sulphate  Effervescent tablets 125mg(45mg elemental zinc)
    06.06.02 Zolendronic Acid Aclasta® Injection 4mg
    Injection 5mg

    Initiation on the advice of a specialist
    04.08.01 Zonisamide Zonegran® Capsules 25mg, 50mg, 100mg

    Initiation on the advice of a Neurologist
    04.01.01 Zopiclone  Tablets 3.75mg, 7.5mg
    First choice hypnotic in primary care
    04.02.01 Zuclopenthixol Acetate Clopixol Acuphase® Injection 50mg/ml
    04.02.02 Zuclopenthixol Decanoate Clopixol® Injection 200mg/ml, 500mg/ml
    04.02.01 Zuclopenthixol Dihydrochloride Clopixol® Tablets 2mg, 10mg, 25mg
    Harrogate & Rural District Formulary